Article 8 of The Rome Statute of The International Criminal Court (ICC) defines biological experiments as war crimes. The US, however, is not a state party to the international treaty, and cannot be held  accountable for its war crimes.

LAST MINUTE

MAY 11, 2022: NEW DAMNING BRIEFING BY RUSSIAN ARMY

Briefing on the results of the analysis of documents related to the military biological activities of the United States on the territory of Ukraine

Russian Defence Ministry, May 11, 2022

Download the slides here

“The Russian Defence Ministry continues to study materials on the implementation of military biological programs of the United States and its NATO allies on the territory of Ukraine.

We have already mentioned Robert Pope, director of the Cooperative Threat Reduction Programme and author of the idea of the Central Depository of Highly Dangerous Microorganisms in Kiev.

In his statement of April 10, 2022, Pope said that “…there is no reason to claim that research related to the development of biological weapons is taking place in Ukraine…”. He previously claimed that “…the Americans did not find biological weapons when they first started working with Ukraine, and they still haven’t. In addition, Ukraine lacks the infrastructure to develop and produce biological weapons…”.

I would like to recall that the term “biological weapons” includes biological formulations that contain pathogenic micro-organisms and toxins, as well as the means of delivery and use of said formulations.

While the priority for Ukrainian healthcare is socially significant diseases such as HIV, poliomyelitis, measles and hepatitis, US customers are interested in a completely different nomenclature: cholera, tularemia, plague and hantaviruses.

As a result of the special military operation on the territory of Ukraine, facts of work with the specified pathogens, which are potential agents of biological weapons, have been revealed. At the same time, it was noted that Ukraine had sent a request to the manufacturing company regarding the possibility of equipping the Bayraktar drones with aerosol equipment.

In addition on March 9, three unmanned aerial vehicles equipped with 30-litre containers and equipment for spraying formulations were detected by Russian reconnaissance units in Kherson region. At the end of April, 10 more were found near Kakhovka.

All this information calls into question the statements of American experts.

We have previously provided a scheme for US coordination of biological laboratories and research institutes in Ukraine. Its preliminary analysis suggests that Ukraine is essentially a testing ground for the development of biological weapons components and the testing of new samples of pharmaceuticals.

The Russian Ministry of Defence was able to clarify the said scheme.

It should be noted that the ideologues of US military-biological activities in Ukraine are the leaders of the Democratic Party.

Thus, through the US executive branch, a legislative framework for funding military biomedical research directly from the federal budget was formed. Funds were raised under state guarantees from NGOs controlled by the Democratic Party leadership, including the investment funds of the Clintons, Rockefellers, Soros and Biden.

The scheme involves major pharmaceutical companies, including Pfizer, Moderna, Merck and the US military-affiliated company Gilead. U.S. experts are working to test new medicines that circumvent international safety standards. As a result, Western companies are seriously reducing the cost of research programmes and gaining a significant competitive advantage.

The involvement of controlled nongovernmental and biotechnological organisations, and the increase in their revenues, allows the leaders of the Democratic Party to generate additional campaign finance and hide its distribution.

In addition to US pharmaceutical companies and Pentagon contractors, Ukrainian state agencies are involved in military bioweapons activities, whose main tasks are to conceal illegal activities, conduct field and clinical trials and provide the necessary biomaterial.

Thus, the US Department of Defence, using a virtually internationally uncontrolled test site and the high-tech facilities of multinational companies, has greatly expanded its research capabilities, not only in the field of biological weapons, but also in gaining knowledge about antibiotic resistance and the antibodies to specific diseases in populations in specific regions.

It should be noted that not only the US, but also a number of its NATO allies are implementing their military-biological projects in Ukraine.

The German government has decided to launch a national biosafety programme independent of Washington, D.C., starting in 2013. Twelve countries, including Ukraine, are involved in the Programme.

On the German side, the programme involves the Institute for Armed Forces Microbiology (Munich), the Robert Koch Institute (Berlin), the Loeffler Institute (Greifswald) and the Nocht Institute for Tropical Medicine (Hamburg).

New documents reveal that between 2016 and 2019 alone, three and a half thousand blood serum samples of citizens living in 25 regions of Ukraine were taken by military epidemiologists from the Bundeswehr Microbiology Institute.

The involvement of institutions subordinate to the Bundeswehr confirms the military orientation of biological research carried out in Ukrainian laboratories and raises questions about the goals pursued by the German armed forces in collecting biomaterials of Ukrainian citizens.

The documents obtained also show the involvement of Poland in Ukrainian biolaboratories. The participation of the Polish Institute of Veterinary Medicine in research aimed at assessing the epidemiological threats and spread of the rabies virus in Ukraine has been confirmed. Characteristically, the research in question was carried out jointly with the US-based Battelle Institute, a key contractor for the Pentagon.

In addition, Polish funding for the Lvov Medical University, which includes a member of US military biology projects, the Institute of Epidemiology and Hygiene, has been documented. The organisation has been running a retraining programme for specialists with experience of working with dual-use materials and technologies since 2002.

The special military operation by Russian troops succeeded in obtaining additional information about bio-incidents in Ukraine.

For example, materials indicating the intentional use of a multidrug-resistant tuberculosis pathogen in 2020 to infect the population of the Slavyanoserbsky district of the LPR were examined.

The flyers, made in the form of counterfeit currency notes, were infected with the tuberculosis agent and distributed to minors in Stepovoe village. The organisers of this crime took into account the behaviour of children, who have a habit of “putting everything in their mouths” and taking food with unwashed hands.

The results of bacteriological studies have confirmed the resistance of the isolated bacteria to first- and second-line anti-TB drugs, meaning that the disease caused by them is much more difficult to treat and the cost of treatment is much higher.

According to the conclusion of the Lugansk Republican Sanitary and Epidemiological Station, “…the contamination of the notes was most likely carried out artificially, as the material contains extremely dangerous strains of the pathogen in concentrations capable of ensuring infection and development of the tuberculosis process…”.

In his conclusion, the chief doctor of the Lugansk Republican TB Dispensary also notes that “…there are all signs of deliberate, man-made contamination of the flyers with highly pathogenic biomaterial…”.

We previously reported on trials of potentially dangerous biological drugs on one of the least protected categories of people – patients of the Kharkov Regional Clinical Psychiatric Hospital No 3.

We have received new information revealing details of the Pentagon’s inhuman experiments on Ukrainian citizens in Psychiatric Hospital No 1 (Streleche village, Kharkov region). The main category of subjects was a group of male patients aged 40-60 years with a high stage of physical exhaustion.

In order to conceal their US affiliation, the biological research experts travelled via third countries. Here is a photograph of Florida native Linda Oporto, who was directly involved in these works.

In January 2022, the foreign nationals conducting the experiments were evacuated in an emergency and the equipment and drugs they were using were taken to western Ukraine.

Russian Defence Ministry specialists have carried out work directly in two biolaboratories in Mariupol.

Evidence of emergency destruction of documents confirming work with the US military establishment was obtained. A preliminary analysis of extant documentation indicates the use of Mariupol as a regional centre for cholera pathogen collection and certification. The selected strains were sent to the Public Health Centre in Kiev, which is responsible for the onward shipment of biomaterials to the United States. These activities have been carried out since 2014, as evidenced by the transfer of strains.

An act of destruction of the pathogen collection dated February 25, 2022, according to which cholera, tularemia and anthrax pathogens were handled there, was found in the sanitary and epidemiological laboratory.

Part of the collection of the veterinary laboratory was not destroyed in a hurry. In order to ensure safety and secure storage, 124 strains were exported by Russian specialists and their study was organised.

The presence in the collection of pathogens that are uncharacteristic of veterinary medicine, such as typhoid, paratyphoid fever and gas gangrene, is a cause for concern. This could indicate the laboratory’s misuse and involvement in a military biological programme.

We will continue to examine the full volume of material received from the Mariupol biolaboratories and will inform you about the results.

The Russian Ministry of Defence has information that provocations are being prepared to accuse the Russian Armed Forces of using weapons of mass destruction, followed by a “Syrian scenario” investigation to fabricate the necessary evidence and assign blame.

The high likelihood of such provocations is confirmed by requests from the Kiev administration for personal skin and respiratory protection equipment that provides protection against toxic chemicals and biological contaminating agents. The supply to Ukraine of organophosphorus poisoning antidotes raises concerns. In 2022 alone, more than 220,000 ampoules of atropine, as well as preparations for special treatment and disinfection, were delivered from the USA at the request of the Ukrainian Ministry of Health.

Thus, the information obtained confirms that the United States is implementing an offensive military-biological programme in Ukraine to study the possibility of forming controlled epidemics in specific territories.

The special military operation of the Russian Armed Forces has crossed the US military-biological expansion in Ukraine and stopped criminal experiments on civilians.” – RUSSIA MOD

Yeah, everything from any government has to be taken with a pinch of salt and all that, but when things easily corroborate with what we previously discovered, we need to pay attention. I can’t argue anything against the new data yet, but we can cross-reference a lot of it, so, rather than a bombshell, this is more like cementing the foundation and filling in some gaps.

ONE MONTH EARLIER:

TWO MONTHS EARLIER

Top US Biological Weapons Expert Supports and Escalates Russia’s Allegations about Ukraine’s Biolabs

THE FULL STORY SO FAR

She originated all our revelations and public debate and this is her first lengthy interview lately!
Thank her and be a part of the solution by spreading this!
This very post, precisely.
WATCH HERE

US fired back at Russia with very symmetrical accusations. Many are correct. That doesn’t let either of the parts off the hook, both are dirty and guilty, both are a reflection of each other, like commies and nazis, libtards and trumptards, Pepsi and Coke, all eventually owned by some Blackrock.

EARLY GAIN-OF-FUNCTION AND BIOWEAPONS RESEARCH IN USSR AND RUSSIA – RARE INSIDER REPORT

Xinhua news agency released this 3h prior to this update

Bat coronavirus found in U.S.-funded bio-lab in Ukraine: Russian Defense Ministry

A second shout from China to US came up shortly after, a ping-pong match has just started, I’ll only report the most decisive strikes from now on:

“Dismissing the concerns about US biolabs in Ukraine is irresponsible” – China’s second shout to US

UPDATE MARCH 08, 2022

BREAKING! China demands inspections at 360 US-ran biolabs around the world, including Ukraine.

Only hours later, Victoria Nuland, US Undersecretary of State, replied. They’ve never reacted so promptly, definitely a massive burning issue to US:

How did we get here? See below!

UPDATE FEB. 25, 2022

In the context of the Russian military operations in Ukraine, the US Embassy removed all their Ukraine Bioweapon lab documents from their website.

Sort of.

The good news is they are still archived (Thanks Flaming Sword)

https://web.archive.org/web/20170130193016/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-kharkiv-eng.pdf

https://web.archive.org/web/20210511164310/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-luhansk-eng.pdf

https://web.archive.org/web/20170221125752/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-dnipropetrovsk-eng.pdf

https://web.archive.org/web/20210506053014/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-vinnitsa-eng.pdf

https://web.archive.org/web/20170221125752/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-dnipropetrovsk-eng.pdf

https://web.archive.org/web/20170207122550/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-kherson-fact-sheet-eng.pdf

https://web.archive.org/web/20170223011502/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-ternopil-fact-sheet-eng.pdf

https://web.archive.org/web/20170208032526/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-zakarpatska-fact-sheet-eng.pdf

https://web.archive.org/web/20170208032526/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-zakarpatska-fact-sheet-eng.pdf

https://web.archive.org/web/20170202040923/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-lviv-dl-eng.pdf

https://web.archive.org/web/20170201004446/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-lviv-rdvl-eng.pdf

https://web.archive.org/web/20161230143004/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-eidss.pdf

https://web.archive.org/web/20210506212717/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-pathogen-asset-control.pdf

https://web.archive.org/web/20170207153023/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-dnipropetrovsk-rdvl_eng.pdf

https://web.archive.org/web/20170211022339/https://photos.state.gov/libraries/ukraine/895/pdf/kiev-ivm-fact-sheet-eng.pdf

The Pentagon Bioweapons

by Dilyana Gaytandzhieva

Dilyana Gaytandzhieva is a Bulgarian investigative journalist, Middle East correspondent and founder of Arms Watch. Over the last two years she has published a series of revealing reports on weapons supplies to terrorists in Syria and Iraq. Her current work is focused on documenting war crimes and illicit arms exports to war zones around the world.

Attention: for expired/deleted links, learn to use the Wayback Machine from the Internet Archive, their apps and plugins are great.

The US Army regularly produces deadly viruses, bacteria and toxins in direct violation of the UN Convention on the prohibition of Biological Weapons. Hundreds of thousands of unwitting people are systematically exposed to dangerous pathogens and other incurable diseases.  Bio warfare scientists using diplomatic cover test man-made viruses at Pentagon bio laboratories in 25 countries across the world. These US bio-laboratories are funded by the Defense Threat Reduction Agency (DTRA) under a $ 2.1 billion military program– Cooperative Biological Engagement Program (CBEP), and are located in former Soviet Union countries such as Georgia and Ukraine, the Middle East, South East Asia and Africa.

Georgia as a testing ground

The Lugar Center is the Pentagon bio laboratory in Georgia. It is located just 17 km  from the US Vaziani military airbase in the capital Tbilisi. Tasked with the military program are biologists from the US Army Medical Research Unit-Georgia (USAMRU-G) along with private contractors. The Bio-safety Level 3 Laboratory is accessible only to US citizens with security clearance. They are accorded diplomatic immunity under the 2002 US-Georgia Agreement on defense cooperation.

The Lugar Center, Republic of Georgia
The US Army has been deployed to Vaziani Military Air Base, 17 km from the Pentagon bio-laboratory at The Lugar Center.
The USA-Georgia agreement accords diplomatic status to the US military and civilian personnel (including diplomatic vehicles), working on the Pentagon program in Georgia.

Information obtained from the US federal contracts registry clarifies some of the military activities at The Lugar Center – among them research on bio-agents (anthrax, tularemia) and viral diseases (e.g. Crimean-Congo Hemorrhagic Fever), and the collection of biological samples for future experiments.

DTRA Chief: “We provided safe and secure storage for deadly pathogens in former USSR countries” 2009

Pentagon contractors produce bio agents under diplomatic cover

The Defense Threat Reduction Agency (DTRA) has outsourced much of the work under the military program to private companies, which are not held accountable to  Congress, and which can operate more freely and move around the rule of law.  US civilian personnel performing work at The Lugar Center have also been given diplomatic immunity, although they are not diplomats. Hence, private companies can perform work, under diplomatic cover, for the US government without being under the direct control of the host state – in this case  the Republic of Georgia. This practice is often used by the CIA to provide cover for its agents. Three private American companies work at the US bio-laboratory in Tbilisi – CH2M Hill, Battelle and Metabiota. In addition to the Pentagon, these private contractors perform research for the CIA and various other government agencies.

CH2M Hill has been awarded $341.5 million DTRA contracts under the Pentagon’s program for bio-laboratories in Georgia, Uganda, Tanzania, Iraq, Afghanistan, South East Asia. Half of this sum ($161.1 million), being allocated to The Lugar Center, under the Georgian contract. According to CH2M Hill, the US Company has secured biological agents and employed former bio warfare scientists at The Lugar Center. These are scientists who are working for another American company involved in the military program in Georgia – Battelle Memorial Institute.

Battelle as a $59 million subcontractor at Lugar Center has extensive experience in research on bio-agents, as the company has already worked on the US Bio-weapons Program under 11 previous contracts with the US Army (1952-1966).Source: US Army Activities in the US, Biological Warfare Programs, vol. II, 1977, p. 82

The private company performs work for the Pentagon’s DTRA bio laboratories in Afghanistan, Armenia, Georgia, Uganda, Tanzania, Iraq, Afghanistan and Vietnam. Battelle conducts research, development, testing, and evaluation using both highly toxic chemicals and highly pathogenic biological agents for a wide range of US government agencies. It has been awarded some $2 billion federal contracts in total and ranks 23 on the Top 100 US government contractors list.

2020: Al Jazeera inside Georgian biolab: “I’m no scientist but their research is ok by the looks of the lab

As opposed to this Al Jazeera dude, we’re not working for corporations or governments and there’s no government that can put up with our research. Dilyana is anti-Russian, I am against any large group of people that’s not a music festival audience or a tree-planting brigade, they’re all dumb and only harmonic vibrations can redeem them.

The CIA-Battelle Project Clear Vision

Project Clear Vision (1997 and 2000), a joint investigation by the CIA and the Battelle Memorial Institute, under a contract awarded by the Agency, reconstructed and tested a Soviet-era anthrax bomblet in order to test its dissemination characteristics. The project’s stated goal was to assess bio-agents dissemination characteristics of bomblets. The clandestine CIA-Battelle operation was omitted from the US Biological Weapons Convention declarations submitted to the UN.

Top Secret Experiments

Battelle has operated a Top Secret Bio laboratory (National Biodefense Analysis and Countermeasures Center – NBACC) at Fort Detrick, Maryland under a US Department of Homeland Security (DHS) contract for the last decade. The company has been awarded a $344.4 million federal contract (2006 – 2016) and another $17.3 million  contract (2015 -2026) by DHS.

NBACC is classified as a US Top Secret facility. Photo credit: DHS

Amongst the secret experiments, performed by Battelle at NBACC, are: Assessment of powder dissemination technology Assessment of hazard posed by aerosolized toxins  and Assessment of virulence of B. Pseudomallei (Meliodosis) as a function of aerosol particle in non-human primates. Melioidosis has the potential to be developed as a biological weapon, hence, it is classed as a category B. Bioterrorism Agent.  B. Pseudomallei was studied by the US as a potential bioweapon in the past.

Besides the military experiments at the Lugar Center in Georgia, Battelle has already produced bioterrorism agents at the Biosafety Level 4 NBACC Top Secret Laboratory at Fort Detrick in the US. A NBACC presentation lists 16 research priorities for the lab. Amongst them to characterize classical, emerging and genetically engineered pathogens for their BTA (biological threat agent) potential; assess the nature of nontraditional, novel and non-endemic induction of disease from potential BTA and to expand aerosol-challenge testing capacity for non-human primates.

Scientists engineer pathogens at the NBACC lab. Photo credit: NBACC

The US Company Metabiota Inc. has been awarded $18.4 million federal contracts under the Pentagon’s DTRA program in Georgia and Ukraine for scientific and technical consulting services. Metabiota services include global field-based biological threat research, pathogen discovery, outbreak response and clinical trials. Metabiota Inc. had been contracted by the Pentagon to perform work for DTRA before and during the Ebola crisis in West Africa and was awarded $3.1 million (2012-2015) for work in Sierra Leone – one of the countries at the epicenter of the Ebola outbreak.

Metabiota worked on a Pentagon’s project at the epicenter of the Ebola crisis, where three US biolabs are situated.

July 17, 2014 report drafted by the Viral Hemorrhagic Fever Consortium, accused Metabiota Inc. of failing to abide by an existing agreement on how to report test results and for bypassing the Sierra Leonean scientists working there. The report also raised the possibility that Metabiota was culturing blood cells at the lab, something the report said was dangerous, as well as misdiagnosing healthy patients. All of those allegations were  denied by Metabiota.

2011,The Lugar Center, Andrew C. Weber (on the right) – US Assistant Secretary of Defense (2009-2014), US DoD Deputy Coordinator for Ebola Response (2014-2015), is currently a Metabiota ( the US contractor) employee.

[Keep these guys in mind for later! – S.m.]

Military Experiments on biting insects

Entomological warfare is a type of biological warfare that uses insects to transmit diseases. The Pentagon has allegedly performed such entomological tests in Georgia and Russia. In 2014 The Lugar Center was equipped with an insect facility and launched a project “Raising Awareness about Barcoding of Sand Flies in Georgia and Caucasus”. The project covered a larger geographic area outside of Georgia – Caucasus. In 2014-2015 Phlebotomine sand fly species were collected under another project “Surveillance Work on Acute Febrile Illness” and all (female) sand flies were tested to determine their infectivity rate. A third project, also including sand flies collection, studied the characteristics their salivary glands.

             A biting fly in a bathroom in Tbilisi (photo 1), flies in Georgia (photo 2, 3)

As a result Tbilisi has been infested with biting flies since 2015. These biting insects live indoors, in bathrooms, all year long, which was not the typical behaviour of these species in Georgia previously (normally the Phlebotomine fly season in Georgia is exceptionally short – from June to September). Local people complain of being bitten by these newly appeared flies while naked in their bathrooms. They also have a strong resistance to cold and can survive even in the sub-zero temperatures in the mountains.

Biting Flies in Dagestan, Russia

 Since the start of the Pentagon project in 2014 flies similar to those in Georgia have appeared in neighboring Dagestan (Russia). According to local people, they bite and cause rashes. Their breeding habitats are house drains.

                                     Flies in Georgia (on the left). The same species in Dagestan (on the right)

Flies from the Phlebotomine family carry dangerous parasites in their saliva which they transmit through a bite to humans. The disease, which these flies carry, is of high interest to the Pentagon. In 2003 during the US invasion of Iraq American soldiers were severely bitten by sand flies and contracted Leishmoniasis. The disease is native to Iraq and Afghanistan and if left untreated the acute form of Leishmoniasis can be fatal.

1967 US Army report “Arthropods of medical importance in Asia and the European USSR” lists all local insects, their distribution and the diseases that they carry. Biting flies, which live in drains, are also listed in the document. Their natural habitats, though, are the Philippines, not Georgia or Russia.

Source: “Arthropods of medical importance in Asia and the European USSR”, US Army report, 1967
DTRA 2008: “We design and test weapon systems and pathogens”

Operation Whitecoat: Infected flies tested to bite humans

Sand fly

In 1970 and 1972, Sand Fly Fever tests were performed on humans according to a declassified US Army report – US Army Activities in the US, Biological Warfare Programs, 1977, vol. II, p. 203. During operation Whitecoat volunteers were exposed to bites by infected sand flies. Operation Whitecoat was a bio-defense medical research program carried out by the US Army at Fort Detrick, Maryland between 1954 and 1973.

Despite the official termination of the US bio-weapons program, in 1982 USAMRIID performed an experiment if sand flies and mosquitoes could be vectors of Rift Valley Virus, Dengue, Chikungunya and Eastern Equine Encephalitis – viruses, which the US Army researched for their potential as bio-weapons.

Killer Insects

A. Aegupti

The Pentagon has a long history in using insects as vectors for diseases. According to a partially declassified 1981 US Army report, American bio warfare scientists carried out a number of experiments on insects. These operations were part of the US Entomological Warfare under the Program for Biological Weapons of the US.

The Pentagon: How to kill 625,000 people for just $0.29 cost per death

A US Army report in 1981 compared two scenarios – 16 simultaneous attacks on a city by A. Aegupti mosquitoes, infected with Yellow Fever, and Tularemia aerosol attack, and assesses their effectiveness in cost and casualties.

Operation Big Itch: Field tests were performed to determine coverage patterns and survivability of the tropical rat flea Xenopsylla cheopis for use as a disease vector in biological warfare.

Operation Big Buzz: 1 million A. Aeugupti mosquitoes were produced, 1/3 were placed in munitions and dropped from aircraft, or dispersed on the ground. The mosquitoes survived the airdrop and actively sought out human blood.

Source: Evaluation of Entomological Warfare as a potential Danger to the US and European NATO nations, US Army, March 1981 Report

Operation May Day: Aedes Aegupti mosquitoes were dispersed through ground based methods in Georgia, USA, during a US Army operation codenamed May Day.

Parts of the 1981 US Army report such as the “Mass production of Aedes Aegypti” have not been declassified, potentially meaning that the project is still ongoing.

Aedes Aegyptialso known as yellow fever mosquito, have been widely used in US military operations. The same species of mosquitoes are alleged to be the vectors of dengue, chikungunya and the Zika virus, which causes genetic malformations in newborns.

Operation Bellweather  

The US Army Chemical Research and Development Command, Biological Weapons Branch, studied outdoor mosquito biting activity in a number of field tests at Dugway Proving Ground, Utah, in 1960. Virgin female Aedes aegypti mosquitoes, which had been starved, were tested upon troops out in the open air.

   For reference: Outdoor Mosquito Biting Activity Studies, Project Bellweather I, 1960, Technical Report, US Army, Dugway Proving Ground

Military Experiments with Tropical Mosquitoes and Ticks in Georgia

Such species of mosquitoes and fleas (studied in the past under the US Entomological Warfare Program) have also been collected in Georgia and tested at The  Lugar Center.

Under the DTRA project “Virus and Other Arboviruses in Georgia” in 2014 the  never-before-seen tropical mosquito Aedes albopictus was detected for the first time and after decades (60 years) the existence of Aedes Aegypti mosquito was confirmed in West Georgia.

Aedes Albopictus is a vector of many viral pathogens, Yellow fever virus, Dengue, Chikungunya and Zika.

These tropical mosquitoes Aedes Albopictus having never been seen before in Georgia, have also been detected in neighboring Russia (Krasnodar) and Turkey, according to data provided by the European Centre for Disease Prevention and Control. Their spread is unusual for this part of the world.

Aedes Aegupti Mosquitoes have been distributed only in Georgia, Southern Russia and Northern Turkey. They were detected for the first time in 2014 after the start of the Pentagon program at The Lugar Center.

Under another DTRA project  “Epidemiology and Ecology of Tularemia in Georgia” (2013-2016)  6,148 ground ticks were collected ; 5,871 were collected off the cattle and 1,310 fleas and 731 ticks were caught. In 2016 a further 21 590 ticks were collected and studied at The Lugar Center.

Anthrax Outbreak in Georgia and NATO Human Trials

In 2007 Georgia ended its policy of having compulsory annual livestock anthrax vaccination. As a result, the morbidity rate of the disease reached its peak in 2013. The same year NATO started human based anthrax vaccine tests at The Lugar Center in Georgia.

     In 2007 despite the anthrax outbreak the Georgian government terminated the compulsory vaccination for 7 years, 2013 saw NATO start human trials on a new anthrax vaccine in Georgia.

Pentagon Research on Russian Anthrax 

Anthrax is one of the bio agents weaponized by the US Army in the past. Despite the Pentagon’s claims that its program is only defensive, there are facts to the contrary. In 2016 at The Lugar Center American scientists carried out research on the “Genome Sequence of the Soviet/Russian Bacillus anthracis Vaccine Strain 55-VNIIVViM”, which was funded by the U.S. Defense Threat Reduction Agency’s (DTRA) Cooperative Biological Engagement Program in Tbilisi, and administered by Metabiota (the US contractor under the Pentagon program in Georgia).

In 2017 the  DTRA funded further research – Ten Genome Sequences of Human and Livestock Isolates of Bacillus anthracis from the Country of Georgia, which was performed by USAMRU-G at The  Lugar Center.

34 people infected with Crimean-Congo Hemorrhagic Fever (CCHF) in Georgia

Crimean-Congo hemorrhagic fever (CCHF) is caused by infection through a tick-borne virus (Nairovirus). The disease was first characterized in Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in Congo, thus resulting in the current name of the disease. In 2014 34 people became infected (among which a 4-year old child) with CCHF. 3 of which died. The same year Pentagon biologists studied the virus in Georgia under the DTRA project “Epidemiology of febrile illnesses caused by Dengue viruses and other Arboviruses in Georgia. The project included tests on patients with fever symptoms and the collection of ticks, as possible vectors of CCHV for laboratory analysis.

 
34 people became infected with CCHF, 3 of them died in Georgia. Source: NCDC-Georgia

The cause of the CCHF outbreak in Georgia is still unknown. According to the local Veterinary Department report, only one tick from all of the collected species from the infected villages tested positive for the disease. Despite the claims of the local authorities that the virus was transmitted to humans from animals, all animal blood samples were negative too. The lack of infected ticks and animals is inexplicable given the sharp increase of CCHF human cases in 2014, meaning that the outbreak was not natural and the virus was spread intentionally.

In 2016 another 21 590 ticks were collected for DNA database for future studies at The Lugar Center under the Pentagon project “Assessing the Seroprevalence and Genetic Diversity of Crimean-Congo Hemorrhagic Fever Virus (CCHFV) and Hantaviruses in Georgia”.

Symptoms of CCHF

Military bio-lab blamed for deadly CCHF outbreak in Afghanistan

237 cases of Crimean-Congo Hemorrhagic Fever (CCHF) have also been reported across Afghanistan, 41 of which were fatal as of December 2017. According to Afghanistan’s Ministry of Health most of the cases have been registered in the capital Kabul where 71 cases have been reported with 13 fatalities, and in the province of Herat near the border with Iran (67 cases).

Afghanistan is one of 25 countries across the world with Pentagon bio-laboratories on their territory. The project in Afghanistan is part of the US bio-defense program – Cooperative Biological Engagement Program (CBEP), which is funded by the Defense Threat Reduction Agency (DTRA). The DTRA contractors, working at The Lugar Center in Georgia, CH2M Hill and Battelle have also been contracted for the program in Afghanistan. CH2M Hill has been awarded a $10.4 million contract (2013-2017). The Pentagon contractors in Afghanistan and Georgia are the same and so are the diseases which are spreading among the local population in both countries.

Why the Pentagon collects and studies bats

Bats are allegedly the reservoir hosts to the Ebola Virus , Middle East Respiratory Syndrome (MERS) and other deadly diseases. However, the precise ways these viruses are transmitted to humans are currently unknown. Numerous studies have been performed under the DTRA Cooperative Biological Engagement Program (CBEP) in a search for deadly pathogens of military importance in bats.

                                 221 bats were euthanized at the Lugar Center for research purposes in 2014.

Bats have been blamed for the deadly Ebola outbreak in Africa (2014-2016). However, no conclusive evidence of exactly how the virus “jumped” to humans has ever been provided, which raises suspicions of intentional and not natural infection.

This comes from the set of evidences Russia made public prior to convoking a UN meeting on March 11 2022

Engineering deadly viruses is legal in the US

MERS-CoV  is thought to originate from bats and spread directly to humans and/or camels. However, like Ebola, the precise ways the virus spreads are unknown. 1,980 cases with 699 deaths were reported in 15 countries across the world (as of June 2017) caused by MERS-CoV.

       3 to 4 out of every 10 patients reported with MERS have died (Source: WHO)

MERS-CoV is one of the viruses that have been engineered by the US and studied by the Pentagon, as well as Influenza and SARS. Confirmation of this practice is   Obama’s 2014 temporary ban on government funding for such “dual-use” research. The moratorium was lifted in 2017 and experiments have continued. Enhanced Potential Pandemic Pathogens (PPPs) experiments are legal in the US. Such experiments aim to increase the transmissibility and/or virulence of pathogens.

Tularemia as Bioweapon

F. Tularensis is a highly infectious bacterium and has the potential to be weaponized for use through aerosol attacks.

Tularemia, also known as Rabbit Fever, is classified as a bioterrorism agent and was developed in the past as such by the US. However, the Pentagon’s research on tularemia continues, as well as on possible vectors of the bacteria such as ticks and rodents which cause the disease. The DTRA has launched a number of projects on Tularemia along with other especially dangerous pathogens in Georgia. Especially Dangerous Pathogens (EDPs), or select agents, represent a major concern for the  public health globally. These highly pathogenic agents have the potential to be weaponized with proof of their military importance seen through the following Pentagon projects: Epidemiology and Ecology of Tularemia in Georgia (2013-2016)   (60 000 vectors were collected for strain isolates and genome research); Epidemiology of Human Tularemia in Georgia and Human Disease Epidemiology and Surveillance of Especially Dangerous Pathogens in Georgia (study of select agents among patients with undifferentiated fever and hemorrhagic fever/septic shock).

   Tularemia is one of the bio-weapons that the US Army developed in the past. Source: 1981 US Army Report

Pentagon bio-laboratories spread diseases in Ukraine

The DoD Defense Threat Reduction Agency (DTRA) has funded 11 bio-laboratories in the former Soviet Union Country Ukraine, bordering on Russia.

The US military program is sensitive information

Ukraine has no control over the military bio-laboratories on its own territory. According to the 2005 Agreement between the US DoD and the Ministry of Health of Ukraine the Ukrainian government is prohibited from public disclosure of sensitive information about the US program and Ukraine is obliged to transfer to the US Department of Defense (DoD) dangerous pathogens for biological research. The Pentagon has been granted access to certain state secrets of Ukraine in connection with the projects under their agreement. 

Biowarfare scientists under diplomatic cover

Among the set of bilateral agreements between the US and Ukraine is the establishment of the Science and Technology Center in Ukraine (STCU) – an International organization funded mainly by the US government which has been accorded diplomatic status. The STCU officially supports projects of scientists previously involved in the Soviet biological weapons program. Over the past 20 years the STCU has invested over $285 million in funding and managing some 1,850 projects of scientists who previously worked on the development of weapons of mass destruction.

The US personnel in Ukraine work under diplomatic cover.

364 Ukrainians died from Swine Flu

One of the Pentagon laboratories is located in Kharkiv, where in January 2016 at least 20 Ukrainian soldiers died from Flu-like virus in just two days with 200 more being hospitalized. The Ukrainian government did not report on the dead Ukrainian soldiers in Kharkiv. As of March 2016  364 deaths have been reported across Ukraine (81.3 % caused by Swine Flu A (H1N1) pdm09 – the same strain which caused the world pandemic in 2009).

       According to DPR intelligence information the US bio lab in Kharkiv leaked the deadly virus.

Police investigate infection with incurable disease

A highly suspicious Hepatitis A infection  spread rapidly in just few months across South East Ukraine where most of the Pentagon biolabs are located.

37 people have been hospitalized for Hepatitis A in the Ukrainian city of Mykolaiv as of January 2018. Local police have launched an investigation into “infection with human immunodeficiency virus and other incurable diseases”. Three years ago more than 100 people in the same city became infected with Cholera. Both diseases are alleged to have spread through contaminated drinking water.

In the summer of 2017 60 people with Hepatitis A were admitted to hospital in the city of Zaporizhia, the cause of this outbreak is still unknown.

In the Odessa region, 19 children from an orphanage were hospitalized for hepatitis A in June 2017.

29 cases of Hepatitis A were reported in Kharkiv in November 2017. The virus was isolated in contaminated drinking water. One of the Pentagon bio-labs is located in Kharkiv which was blamed for the deadly Flu outbreak a year ago which claimed the lives of 364 Ukrainians.

Ukraine and Russia hit by new highly virulent cholera infection

In 2011 Ukraine was hit by a cholera outbreak33 patients were reportedly hospitalized for severe diarrhea. A second outbreak struck the country in 2014 when more than 800 people all across Ukraine were reported to have contracted the disease. In 2015 at least 100 new cases were registered in the city of Mykolaiv alone.

A new highly virulent variant of the cholera agent Vibrio cholera, with a high genetic similarity to the strains reported in Ukraine, hit Moscow in 2014.  According to a 2014 Russian Research Anti-Plaque Institute genetic study the cholera strain isolated in Moscow was similar to the bacteria  which caused the epidemic in neighboring Ukraine.

Southern Research Institute, one of the US contractors working at the bio-laboratories in Ukraine, has projects on Cholera, as well as on Influenza and Zika – all pathogens of military importance to the Pentagon.

Along with Southern Research Institute, two other private American companies operate  military bio-labs in Ukraine – Black&Veatch and Metabiota.

Black & Veatch Special Project Corp. was awarded $198.7 million DTRA contracts to build and operate bio-laboratories in Ukraine (under two 5-year contracts in 2008 and 2012 totaling $128.5 million), as well as in Germany, Azerbaijan, Cameroon, Thailand, Ethiopia, Vietnam and Armenia.

Metabiota has been awarded a $18.4 million federal contract under the program in Georgia and Ukraine. This US company was also contracted to perform work for the DTRA before and during the Ebola crisis in West Africa, the company was awarded $3.1 million (2012-2015) for work in Sierra Leone .

Southern Research Institute has been a prime subcontractor under the DTRA program in Ukraine since 2008. The company was also a prime Pentagon contractor in the past under the US Biological Weapons Program for research and development of bio-agents with 16 contracts between 1951 and 1962.

                                          Source: US Army Activities in the US, Biological Warfare Programs, vol. II, 1977, p. 82

2013: Russia blamed Georgian US-funded biolabs for an epidemic at its borders- VOA

Soviet Defector produced anthrax for the Pentagon

Southern Research Institute was also a subcontractor on a Pentagon program for anthrax research in 2001. The prime contractor being Advanced Biosystems, whose president at that time was Ken Alibek (a former Soviet microbiologist and biological warfare expert from Kazakhstan who defected to the US in 1992).

Ken Alibek was the First Deputy Director of Biopreparat, where he oversaw a program for biological weapon facilities and was the Soviet Union’s main expert on anthrax. After his defection to the US, he was engaged on Pentagon research projects.

$250 000 for lobbying Jeff Sessions for “research for US intelligence”

Southern Research Institute lobbied  the US Congress and US Department of State hard for “issues related to research and development for US intelligence” and “defense related research and development”. The lobbying activities coincided with the start of the Pentagon projects on bio-labs in Ukraine and other former Soviet states.

The company paid $ 250 000 for lobbying the then Senator Jeff Sessions in 2008-2009 (currently the US Attorney General appointed by Donald Trump), when the institute was awarded a number of federal contracts.

      US Attorney General Jeff Sessions, US Senator from Alabama (1997-2017)

Watson Donald

For a 10-year period (2006-2016) Southern Research Institute paid $1.28 million for lobbying the US Senate, House of Representatives , the State Department and the Department of Defense (DoD). Senator Jeff Sessions’ aide on Capitol Hill – Watson Donald, is now a Senior Director at Southern Research Institute.

Police investigate Botulism toxin poisoning in Ukraine

115 Botulism cases, with 12 deaths, were reported in Ukraine in 2016. In 2017 the Ukrainian Ministry of Health confirmed a further 90 new cases, with 8 deaths, of botulinum toxin poisoning (one of the most poisonous biological substances known). According to the local health authorities, the cause of the outbreak was food poisoning into which  police launched an investigation. The Pentagon biolaboratories in Ukraine were among the prime suspects, as botulinum toxin is one of the bioterrorism agents which have already been produced at a Pentagon bioweapons facility in the US. (see below)

The Ukrainian government stopped supplying antitoxin in 2014 and no botulism vaccines in stock were available during the 2016-2017 outbreak. 

Botulism is a rare and extremely dangerous illness caused by a toxin produced by the bacterium Clostridium botulinum.

1 gm of the toxin can kill as many as 1 million people 

Botulinum neurotoxin poses a major bio-weapon threat because of its extreme potency, ease of production and transport. It causes muscles paralyses, respiratory failure and ultimately death if not treated immediately. A single gram of crystalline toxin, evenly dispersed and inhaled can kill more than one million people. It could be disseminated via aerosol, or by contamination of water and/ or food supplies.

The Pentagon produces live Viruses, Bacteria & Toxins

Botulinum Toxin was tested as a bio-weapon by the US Army in the past, as well as Anthrax, Brucella and Tularemia. Although the US bio-weapons program was officially terminated in 1969 documents show that the military experiments have never ended. Presently the Pentagon produces and tests live bio- agents at the same military facility as it did in the past – Dugway Proving Ground.

Current Field Tests

                               Source: Capabilities Report 2012, West Desert Test Center

Past Field Tests

                                Source: 1977 US Army Report, p. 135

Bioweapons factory in the US

The US Army produces and tests bio-agents at a special military facility located at Dugway Proving Ground (West Desert Test Center, Utah), as proven in a 2012 US Army Report. The facility is overseen by the Army Test and Evaluation Command.

 The Life Sciences Division (LSD) at Dugway Proving Ground is tasked with the production of bio-agents. According to the Army report, scientists from this division produce and test aerosolized bio-agents at Lothar Saloman Life Sciences Test Facility (LSTF).

Lothar Saloman Life Sciences Test Facility (LSTF) where bio-terrorism agents are produced and aerosolized. Photo Credit: Dugway Proving Ground
Biological Agents produced by the US Army at Dugway Proving Ground, Utah, USA
Source: Capabilities Report 2012, West Desert Test Center

The Life Sciences Division consists of an Aerosol Technology branch and a Microbiology Branch. The Aerosol Technology Branch aerosolizes biological agents and simulants. The Microbiology branch produces toxins, bacteria, viruses and agent-like organisms which are used in chamber and field testing.

The fermentation laboratories at the Life Sciences Test Facility grow bacteria in fermentors ranging from a small 2 L to a large 1500 L system.  The fermentors are tailored specifically to the requirements of the microorganism that is being engineered – pH, temperature, light, pressure, and nutrient concentrations that give the microorganism optimal growth rates.

A large 1500 L fermentator
A post-production laboratory dries and mills test materials. Photos credit: Dugway Proving Ground

After the bio-agents are produced, the scientists challenge them at containment aerosol chambers.

  Technicians disseminate live biological agents for identification sensitivity tests (photos: Dugway Proving Ground)

Aerosol experiments with Botulinum Neurotoxin and Anthrax

Documents prove that the US Army produces, possesses and tests aerosols of the most lethal toxin in the world – Botulinum Neurotoxin. In 2014 the Department of the Army purchased 100 mg of Botulinum Toxin from Metabiologics for tests at Dugway Proving Ground.

The experiments date back to 2007 when an unspecified quantity of the toxin was procured to the Department of the Army by the same company – Metabiologics. According to the 2012 West Desert Test Center Report, the military facility performs tests with Botulinum Neurotoxin Aerosol, as well as with aerosolized Anthrax, Yersinia pestis, and Venezuelan Equine Encephalitis Virus (VEE).

Source: Capabilities Report 2012, West Desert Test Center

Outdoor field test programs at Dugway Proving Ground

US Army documents and photos show that the Pentagon has developed various dissemination methods for bioterrorism attacks including by explosives.

Source: Capabilities Report 2012, West Desert Test Center
Dissemination of contaminants for biological/chemical tests. Photo credit: Dugway Proving Ground
Dissemination of simulants by explosives. Photo Credit: Dugway Proving Ground
Liquid Dissemination
Powder Dissemination
Dissemination on the test grid. Photos Credit: Dugway Proving Ground
Aerosol Sprayer

The US Army report lists numerous dissemination techniques including by bio-aerosol sprayers. Such sprayers called Micronair disseminators have already been developed by the US Army and tested at Dugway Proving Ground. According to the documents, they can be vehicle-mounted, or worn as a backpack, with a pump system which can be fitted to the unit to increase the accuracy of the release. Micronair sprayers can release 50 to 500 mL of bio-liquid simulant per minute from 12 L tanks.

The US stole bacteria from Saddam Hussein’s bio weapons factory

Bacillus thuringiensis

Bacillus thuringiensis is an insect pathogen that is widely used as a bio-pesticide. B. thuringiensis (BT) Al Hakam was collected in Iraq by the UN Special Commission led by the US in 2003. It is named after Al Hakam – Iraq’s  bio-weapons production facility. Apart from Pentagon field tests, this bacterium is also used in the US for the production of GM corn, resistant to pests. Photos posted by the CIA prove that the bacteria was collected by the US in Iraq. According to the CIA, the vials containing bio-pesticide, were recovered from an Al Hakam scientist’s home.

CIA: A total of 97 vials-including those with labels consistent with the al Hakam cover stories of single-cell protein and bio-pesticides, as well as strains that could be used to produce BW agents were recovered from a scientist’s residence in Iraq in 2003. Photo credit: CIA

Information from the US federal contracts registry shows that the Pentagon performs tests using the bacteria stolen from Saddam Hussein’s bio-weapons factory in Iraq.

The Defense Threat Reduction Agency (DTRA) federal project for laboratory analysis and field tests with bacteria. Source: govtribe.com

The tests are performed at Kirtland Air Force Base (Kirtland is the home of the Air Force Materiel Command’s Nuclear Weapons Center). Here weapons are being tested, meaning that the field tests with biological simulants (bacteria) also fall into this group.

The DTRA contractor on this project – Lovelace Biomedical and Environmental Research Institute (LBERI), operates an Animal Bio-safety 3 Level (ABSL-3) laboratory which has Select Agent status. The facility is designed to conduct bioaerosol studies. The company has been awarded a 5-year contract for field tests with biological simulants at Kirtland Air Force Base.

Photo Credit: Kirtland Air Force Base

Field tests with Biological Simulants (bacteria)

What the Pentagon is now doing is exactly what it did in the past, meaning that its bio-weapons program was never terminated. The US Army performed 27 field tests with such biological simulants, involving the public domain from 1949 to 1968, when President Nixon officially announced the end of the program.

  Source: US Army Activities in the US, Biological Warfare Programs, vol. II, 1977, p. 125-126

Field tests in Chechnya

The Defense Threat Reduction Agency (DTRA), which runs the US military program at the Lugar Center in Georgia, is alleged to have already performed field tests with an unknown substance in Chechnya, Russia. In the spring of 2017 local citizens reported on a drone disseminating white powder close to the Russian border with Georgia. Neither the Georgian border police, nor the US personnel operating on the Georgia-Russia border, commented on this information.

$9.2 million US military project on Russia-Georgia border

DTRA has full access to the Russia-Georgia border, granted under a military program called “Georgia Land Border Security Project”. The activities, related to the project have been outsourced to a private American company – Parsons Government Services International. DTRA has previously contracted Parsons for similar border security projects in Lebanon, Jordan, Libya and Syria. Parsons have been awarded a $9.2 million contract under the Pentagon border security project on the Russia-Georgia border.

Local citizens in Chechnya noticed a UAV sprayer near the Russian border with Georgia in 2017.

US Defense Agency tests GM Insects to transmit GM Viruses

The Pentagon has invested at least $65 million in gene editing. The US Defense Advanced Research Projects Agency (DARPA) has awarded 7 research teams to develop tools for genome engineering in insects, rodents and bacteria under DARPA’s Safe Gene program, using a novel CRISPR-Cas9 technology.

Under another military program –Insect Allies, GM insects are engineered to transfer modified genes to plants. The $10.3 million DARPA project includes both gene editing in insects and in the viruses that they transmit. Ecological Niche-preference Engineering is a third ongoing military program for genome engineering in insects. The Pentagon’s stated objective is to engineer GM organisms so that they can resist certain temperatures, change their habitat and food sources.

Source: fbo.gov

Genetically engineered humans

Besides gene editing in insects and in the viruses they transmit, the Pentagon wants to engineer humans as well. DARPA Advanced Tools for Mammalian Genome Engineering Project seeks to create a biological platform inside the human body, using it to deliver new genetic information, and thus altering humans at the DNA level.

DARPA wants to insert an additional 47th artificial chromosome into human cells. This chromosome will deliver new genes that will be used for engineering the human body. SynPloid Biotek LLC has been awarded two contracts under the program totaling $1.1 million (2015-2016 – $ 100,600 for the first phase of the research; 2015-2017 – $ 999,300 for work which is not specified in the federal contracts registry. The company has only two employees and no previous record on bio-research.

Top Secret Research on Synthetic Viruses

Between 2008 and 2014, the United States invested approximately $820 million in synthetic biology research, Defense being a major contributor. Most of the military projects on synthetic biology are classified, among them are a number of classified studies by the secretive JASON group of US military advisors – e.g. Emerging Viruses and Genome Editing for the Pentagon, and Synthetic Viruses for the National Counterterrorism Center.

JASON is an independent scientific advisory group that provides consulting services to the U.S. government on matters of defense science and technology. It was established in 1960 and most of their resulting JASON reports are classified. For administrative purposes, the JASON’s projects are run by the MITRE Corporation, which has contracts with the Defense Department, CIA and the FBI. Since 2014 MITRE has been awarded some $27.4 million in contracts with the DoD.

Although the JASON Reports are classified, another US Air Force study titled Biotechnology: Genetically Engineered Pathogens, sheds some light on what the secretive JASON group has researched – 5 groups of genetically engineered pathogens that can be used as bio-weapons. These are binary biological weapons (a lethal combination of two viruses), host swapping diseases (animal viruses that “jump” to humans, like the Ebola virus), stealth viruses, and designer diseases. Designer diseases can be engineered to target a certain ethnic group, meaning that they can be used as ethnic bio-weapons.

Ethnic Bioweapons

Ethnic biological weapon (biogenetic weapon) is a theoretical weapon that aims to primarily harm people of specific ethnicities, or genotypes.
Although officially the research and development of ethnic bio-weapons have never been publicly confirmed, documents show that the US collects biological material from certain ethnic groups – Russians and Chinese.

The US Air Force has been specifically collecting Russian RNA and synovial tissue samples, raising fears in Moscow of a covert US ethnic bio-weapons program.

Source: fbo.gov

Apart from Russians, the US has been collecting biological material from both healthy and cancer patients in China. The National Cancer Institute has collected biological samples from 300 subjects from Linxian, Zhengzhou, and Chengdu in China. While another federal project, titled Serum Metabolic biomarkers discovery study of Esophageal Squamous Cell Carcinoma in China, includes analysis of 349 serum samples which have been collected from Chinese patients.

The US National Cancer Institute has been collecting biological material from patients of the Chinese Cancer Hospital in Beijing.

Chinese biological material has been collected under a series of federal projects including saliva and cancer tissue. Among them, Genotyping DNA Samples from Lymphoma cases and from controls (healthy patients), Breast cancer tissue blocks from breast cancer patients, Saliva samples of 50 families who have 3 or more cases of UGI cancer, Genotype 50 SNP’S for DNA samples from the Cancer Hospital, Beijing, Genotypes from 3000 cases of gastric cancer and 3000 controls (healthy patients) in Beijing.

Tobacco Vaccines: How the Pentagon helped tobacco companies to profit from Ebola

The Defense Advanced Research Projects Agency (DARPA) has invested $100 million in vaccines production from tobacco plants. The companies, involved in the project, are owned by the biggest American tobacco companies – Mediacago Incis co-owned by Philip Morris, and Kentucky BioProcessing is a subsidiary of Reynolds American which is owned by British American Tobacco. Currently they are producing Flu and Ebola vaccines from tobacco plants.

The $100 million program Blue Angel was launched as a response to the H1N1 pandemic in 2009. Medicago being awarded $21 million to produce 10, 000 million doses of an influenza vaccine within one month.

Blue Angel program manager Dr. John Julias explains: “Although there are multiple plant species and other organisms being explored as alternative protein production platforms, the US Government has continued to make an investment in tobacco-based manufacturing.”

  The plant-based vaccine production method works by isolating a specific antigen protein that triggers a human immune response from the targeted virus. A gene from the protein is transferred to bacteria, which is used to infect plants. The plants then start producing the protein that will be used for vaccinations (photos: DARPA)

It is not clear why the Pentagon chose to invest in vaccines produced from tobacco plants amongst all other plant species, which they explored. Medicago, co-owned by Philip Morris, paid $495,000 for lobbying the Department of Defensethe Congress and The Department of Health and Human Services for “funding to advance technology to support public health preparedness applications”. The Pentagon funded tobacco companies to develop new technology and to profit from vaccines. – http://dilyana.bg/

Bulgarian journalist confronts US official over secret biolabs

Dilyana Gaytandzhieva gets expelled from a conference on biological weapons at the European Parliament in Brussels after confronting US Assistant Secretary Robert Kadlec.

Authored by Filip Vuković, Balkan Post

On 16 January 2018, a Bulgarian investigative journalist Dilyana Gaytandzhieva wrote a detailed article about the US bio-weapons research that spans across the world in 25 different countries. Gaytandzhieva wrote in her article that the US Army regularly produces deadly viruses, bacteria and toxins in direct violation of the UN Convention on the prohibition of biological weapons, and that hundreds of thousands of unwitting people are systematically exposed to dangerous pathogens and other incurable diseases. She added that bio-warfare scientists are using diplomatic cover test man-made viruses at Pentagon bio-laboratories in 25 countries across the world. These bio-laboratories are funded by the Defense Threat Reduction Agency (DTRA) under a $2.1 billion military program called Cooperative Biological Engagement Program (CBEP), and are located in countries such as Ukraine, Kazakhstan, Uzbekistan, Georgia, Azerbaijan, Jordan, Iraq, Afghanistan, Pakistan, Laos, Cambodia, the Philippines, etc. Luckily, the Balkans seems to be clear.

Gaytandzhieva recently traveled to Brussels and attended the European Parliament in order to confront Robert Kadlec, Assistant Secretary at the US Department of Health, regarding the number of classified bio-weapons research labs scattered through Eastern Europe and Central Asia. Kadlec categorically denied the existence of an American bio-weapon program as well as that information surrounding the labs in question were classified. Gaytandzhieva attempted to continue her follow up but was silenced by Hilde Vautmans, the EU official sitting next to Kadlec, who stated “This is not an investigation” to applause from the audience and an embrace between herself and Kadlec. Gaytandzhieva didn’t stop there, however, following Kadlec to the elevator and continuing to ask him questions regarding the bio-weapons program which Kadlec refused to answer. Security staff then refused to let Gaytandzhieva on the elevator.

Here’s the full transcript of the exchange between Gaytandzhieva and Kadlec:

GaytandzhievaWhy has the Pentagon been operating military bio-laboratories in 25 countries, bordering on the US rivals Russia, China and Iran, and why has the number of deadly outbreaks, in all those countries, increased dramatically since the start of the military program of the United States in these countries?
KadlecI will say unequivocally and undeniably, the US does not have a military biological weapons program. Period. End of statement. Number two [interrupts Gaytandzhieva], we have been working, and I do know from the Department of Defense, they have been working with partners in parts the World, to ensure that those laboratories, and we trained them to do the diagnostic tests on these diseases, to ensure that they can manage them and also safely secure those facilities, so they’re not accessible by terrorists, or by criminals, who would do ill with them.
GaytandzhievaWhy are all these projects classified information? All these bio-laboratories of the Pentagon in 25 countries across the world? Why are they classified information?
KadlecThey’re not classified, they’re openly avaliable to anyone who wants to look at them.
GaytandzhievaNo, I tried it. No, this is not true. They are classified information.
VautmansOk, ok, I think I will not give you more time. We will try to answer your questions, but that’s not the place here. Case closed, thank you very much [kisses with Kadlec].

Gaytandzhieva then followed Kadlec to the elevator and continued to ask him questions regarding the bio-weapons program.

GaytandzhievaJust one more question?
KadlecNo more questions.
GaytandzhievaWhat is the need of military biolaboratories of the United States in 25 countries across the world?

She attempted to enter the elevator, but was forcibly stopped.

GaytandzhievaThis is public area, sorry, I can use the elevator.
Security manSorry not this one, it’s full.
GaytandzhievaI can use the elevator.
Security manNo more questions then [trying to prevent cameraman].
GaytandzhievaWhy not? Why is the Pentagon investing 65 million dolars in gene editing? The gene editing is the part of this program.

Elevator gates closed.

Later, Gaytandzhieva posted the video on her social media pages, simply commenting: “How a journalist gets expelled from the European Parliament when asking the Assistant Secretary at the US Department of Health questions about the Pentagon bio-laboratories around Russia, China and Iran.

Although unable to retrieve any answers from Kadlec, her article is already an impressive collection of information revealing a network of bio-weapons research facilities as well as mysterious outbreaks in their vicinities.

This is not the first time that Gaytandzhieva is exposing the US secret military programs. Last summer, she published a bombshell report which found that an Azerbaijan state airline company was regularly transporting tons of cheap Bulgarian and East European weaponry to Saudi Arabia, United Arab Emirates and Turkey, under diplomatic cover as part of the CIA covert program. These weapons were found inside underground terrorist warehouses belonging to Al Nusra Front, Al Qaeda affiliate in Syria designated as a terrorist organization by the UN. The US modus operandi was the same: using bases in the satellite countries, abuse of diplomatic channels, and dirty politics directed against Russia, Iran and Syria.

2018: Once again, Russia accuses US of running a biological weapons lab in Georgia

New data leak from the Pentagon biolaboratory in Georgia

By Dilyana Gaytandzhieva -September 7, 2020

A diplomatic car with a registration plate of the US Embassy to Tbilisi in the car park of the Lugar Center. US scientists working at the Pentagon laboratory in Georgia drive diplomatic vehicles as they have been given diplomatic immunity (photo: Dilyana Gaytandzhieva)

Leaked e-mails between the Lugar Center, the Pentagon biolaboratory in Tbilisi, the US Embassy to Georgia and the Georgian Ministry of Health reveal new information about the $161 million secretive US Government biological research program in this former Soviet country.

The data allegedly originating from the Ministry of Health of Georgia has been published anonymously on Twitter and on a forum for database leaks – Raidforums. Among the documents there are internal memos, official letters and detailed information about US government projects at the Lugar Center, funding and foreign business trips.

Arms Watch volunteers have analyzed these documents and discovered very interesting facts about the Center’s recent activities.

The Pentagon has planned to turn Georgia into its largest biological research center overseas, combining its military resources with the resources of the US Centers for Disease Control (CDC) in Georgia.

Furthermore, the number of US projects and grants have increased as well as the number of US scientists deployed to the Lugar Center. The Pentagon-funded facility is planned to temporarily accommodate 16 CDC specialists from Atlanta, for whom Georgia will build a separate BSL-2 laboratory, administrative building and a campus near the Lugar Center. In addition, Georgia will become a regional CDC hub for Eastern Europe and Central Asia, internal documents reveal.

The Lugar Center is a $161 million Pentagon-funded biolaboratory in Georgia’s capital Tbilisi (photo: Dilyana Gaytandzhieva)

The Lugar Center already sparked controversy about possible dual-use research in 2018 when leaked documents revealed that US diplomats in Georgia were involved in the trafficking of frozen human blood and pathogens for a secret military program.

The Lugar Center is just one of the many Pentagon biolaboratories in 25 countries across the world. They are funded by the US Defense Threat Reduction Agency (DTRA) under a $ 2.1 billion military program – Cooperative Biological Engagement Program (CBEP), and are located in former Soviet Union countries such as Georgia (the motherland of former Soviet leader Joseph Stalin) and Ukraine, the Middle East, South East Asia and Africa.

DTRA Chief: “We provided safe and secure storage for deadly pathogens in former USSR countries” 2009

Pentagon research on bioterrorism agents at the Lugar Center

US military scientists have been deployed to Georgia for research on bioterrorism agents at the Lugar Center, according to the new data-leak. These bio-agents have the potential to be aerosolized and used as bioweapons. Among them anthrax, tularemia, Brucella, Crimean-Congo Hemorrhagic Fever, Hantavirus, Y. pestis (causing the disease plague).

The US military biological research projects in Georgia have been funded by the Defense Threat Reduction Agency (DTRA). According to internal data, American and Georgian scientists are currently working on the following DTRA projects in the Lugar Center:

Project 1059: Zoonotic Infections with Fever and Skin Injuries in Georgia

The project includes isolation of new orthopoxviruses in humans, rodents, domestic and wild animals in Georgia, and collection of rodents (as a natural reservoir for this virus) for their further study.

Duration: 01/11/2015-31/10/2018 (extended to 2020)

Funding: $702,343

Project 1060: Characterization of the Georgian National Center for Disease Control (NCDC) Strain Repository by New Generation Sequencing

Description: characterization and genome research on 100 strains from four endemic species: Y. pestis (causing the disease plague), B. anthracis (anthrax), Brucella, and F. tularensis (causing the disease tularemia).

Duration: 01/11/2015-31/10/2018

Funding: $ 518,409

Project 1439: Molecular Virological Research in Georgia

Description and objectives:

  • Identify and characterize Hantavirus and Crimean-Congo hemorrhagic fever virus (CCHFV) strains by molecular methods;
  • Characterize and study genetic diversity of Crimean-Congo hemorrhagic fever virus and hantavirus strains isolated from rodents and ectoparasites;
  • Serological examination of febrile patients with Crimean-Congo hemorrhagic fever and hemorrhagic fever with renal syndrome;
  • Collection of rodents and ectoparasites (ticks, fleas);

Duration: 16/08/2017-15/08/2021

Funding: $612,614

Project 1497: Molecular Epidemiology and Ecology of Yersinia Species in Georgia and Azerbaijan

Description: 1) Ecological research on rodents in Kerb on the Georgian-Azerbaijani border 2) Isolation of different strains of Yersinia; 3) Molecular screening of collected rodent and flea samples. 4) A comparative analysis of the genomes of Yersinia strains obtained during the fieldwork; 5) Spatial analysis of the distribution of Yersinia strains.

Duration: 01/09/2017-31/08/2018 (extended to 2022)

Funding: $134,090.00DTRA Projects in Georgia1 of 8  

Project 1742: Risks of bat-borne zoonotic diseases in Western Asia

Duration: 24/10/2018-23 /10/2019

Funding: $71,500

In 2017 the US Defense Threat Reduction Agency (DTRA) launched a $6.5 million project on bats and coronaviruses in Western Asia (Georgia, Armenia, Azerbaijan, Turkey and Jordan) with the Lugar Center being the local laboratory for this genetic research. The duration of the program is 5 years and has been implemented by the non-profit US organisation Eco Health Alliance.

The project’s objectives are: 1. Capture and non-lethally sample 5,000 bats in 5-year period (2017-2022) 2. Collect 20,000 samples (i.e. oral, rectal swabs and/or feces, and blood) and screen for coronaviruses using consensus PCR at regional labs in Georgia and Jordan. According to the project presentation, Eco Health Alliance already sampled 270 bats of 9 species in three Western Asian countries: 90 individual bats in Turkey (Aug 2018), Georgia (Sept 2018), and Jordan (Oct 2018).Video Player00:0003:02

EcoHealth Alliance and Georgian scientists sampling a bat for coronavirus research in 2018 (Facebook, Keti Sidamonidze)

Coincidentally, the same Pentagon contractor tasked with the US DoD bat-research program – Eco Health Alliance, USA, also collected bats and isolated coronaviruses along with Chinese scientists at the Wuhan Institute of Virology. EcoHealth Alliance received a $3.7 million grant from the US National Institutes of Health (NIH) to collect and study coronaviruses in bats in China from 2014 to 2019.

Project 1911: Ricketsia and Coxelia infection surveillance in Georgia and Azerbaijan (US federal grant HDTRA1-19-1-0042 awarded to NCDC-Georgia)

Duration: 23/09/2019 – 22/09/2022

Funding: $945,000

Despite the official claims of Georgia and USA that the Lugar Center is under the full control of the government of this Caucasus country internal documents show otherwise. Not only has the Pentagon funded biological research projects but it has also paid all the expenses for security and maintenance including utility bills – water, gas, electricity, and cleaning. Tasked with the operational and scientific support to the Lugar Center is USAMRU-Georgia, a special unit deployed to Georgia by the Walter Reed Army Institute of Research (WRAIR). WRAIR has paid: $524,625 (2016-2018), $650,000 (2017-2019) and $1,062,400 (2017-2021) for utility bills, and a further $158,050 (2016-2017) and $322,000 (2018-2021) for security guards.

The Pentagon has also awarded a private US contractor, Technology Management Company (TMC) an $8 million contract for science services to support USAMRU-Georgia in the Lugar Center (2016-2021).WRAIR Projects at the Lugar Center1 of 5  

Tularemia research on soldiers

The Pentagon unit USAMRU-Georgia has conducted extensive research on tularemia involving Georgian soldiers, scientific papers reveal.

Tularemia is a rare infectious disease that typically attacks the skin, eyes, lymph nodes and lungs. Tularemia, also called rabbit fever or deer fly fever, is caused by the bacterium Francisella tularensis. It is categorized as a category A bioterrorism agent. Tularemia was weaponized for mass aerosol dissemination by the US Army in the past, according to a recently declassified military report.

Tularemia is one of the bio-weapons that the US Army developed in the past. Source: 1981 US Army Report

900 volunteers (soldiers and civilians) were recruited for the DTRA project GG-19 “Epidemiology and Ecology of Tularemia in Georgia” from 2014 to 2017. Blood samples were collected from those volunteers and tested for tularemia.

According to the study, 10 soldiers (2%) of the 500 solders tested had antibodies for F. tularensis. The seropositive soldiers were men, the majority of whom were between 30 and 39 years of age. Seven cases had current residences in known endemic areas (i.e. Kakheti, Samtskhe-Javakheti, Kvemo Kartli, Shida Kartli, and Tbilisi). Three were from areas without previously known F. tularensis transmission (i.e. Imereti).

Of the 783 residents approached to participate in this study, 35 (5.0%) volunteers had antibodies to F. tularensis.

While the civilian volunteers were all residents of two areas with naturally occurring foci of tularemia in Georgia, the military personnel were soldiers visiting Georgia’s military hospital. The study does not provide any explanation as to why soldiers were enrolled in this project nor how exactly they contracted the disease in the army.Project GG-19: Tularemia in Georgia1 of 8  

Furthermore, Georgia has asked the US Embassy for assistance for the construction of a second military hospital in the country, according to leaked correspondence between local health officials and the US Embassy to Tbilisi.

Below is Google translation in English of this correspondence:

CDC regional hub

The US Government has launched a parallel civil program in Georgia implemented by the US Centers for Disease Control (CDC). Leaked e-mails between the US Embassy to Tbilisi and Georgian health officials reveal that CDC has planned to set up a regional office for Eastern Europe and Central Asia in Georgia. The US Embassy and CDC have requested additional office space for 16 employees. Currently the CDC staff are working inside the Lugar Center.CDC regional hub for Eastern Europe and Central Asia in Georgia1 of 4  

Interestingly, the Georgian health officials do not ask about any further information or clarification as to what this new foreign hub is going to do in their own country. Instead, Georgia’s Ministry of Health has planned the construction of a new BSL-2 laboratory, conference hall and campus near the Lugar Center with a loan from the European Investment Bank, according to a letter to the finance minister of Georgia leaked on Raidforums.

Arms Watch could not independently verify the authenticity of this letter as we did not find it in the leaked files. We have further analyzed the ministry’s internal data and discovered the following CDC projects in Georgia:

Project 1320: Antimicrobial Resistance Project

Duration: 01/09/2016 -29/09/2020

Funding: $153,492.40

Project 1440: Introducing or Expanding the Use of Influenza Vaccine Outside the United States

Duration: 30/09/2016 – 29/09/2019

Funding: $750,000

Project 1441: Influenza Surveillance Outside the United States

Duration: 30/09 / 16-29 / 09/21

Funding: $250,000

Project 1446: Strengthening New Generation Sequencing Capacities for Hepatitis C Surveillance in Georgia

Duration: 01/07/2017-30 /06/2018

Funding: $22,000

Project 1447: Samples collection under the Hepatitis C Elimination Program in Georgia – Bio-Bank

Objective: The aim of the project is to store samples collected under the Hepatitis C program for future scientific work

  • 20,000 plasma/serum samples
  • 6,000 serum samples from the 2015 National Seroprevalence Survey of Hepatitis C and B
  • 1,000 blood samples from blood banks
  • 500 blood samples from patients with terminal liver disease

Duration: 01/07/2017-30/06/2018

Project 1456: Strengthening the micronutrient deficit monitoring system in Georgia

Duration: 01/09/2017 – 31/08/2018

Funding:  $92,875

Project 1457: Genetic peculiarities of hepatitis C virus in Georgia and its role in the Georgian Hepatitis C elimination program

Objective: Evaluate morbidity and mortality associated with Hepatitis C virus

Duration: 01/09/2017-31/08/2018

Funding: $127,125

Project 1532: Strengthening, detection, response and prevention of diarrhea outbreaks in Georgia

Duration: 30/09/2017 -29/09/2020

Funding: $40,000

Project 1533: Strengthening Immunization and Vaccination Control System

Duration: 30/09/2017 – 29/09/2020

Funding: $67,220.00

Project 1534: Respiratory Disease Surveillance

Duration: 30/09/2017 – 29/09/2020

Funding: $80,000.00

Project 1535: Enterovirus surveillance Georgia

Duration: 30/09/2017 -29/ 09/2020

Funding: $45,000

Project 1536: National Laboratory Quality Control Program in Georgia

Duration: 30/09/2017 -29 /09/2020

Funding: $56,140

Project 1537: South Caucasus Field Epidemiology and Laboratory Training Program

Duration: 30/09/2017 -29 /09/2020

Funding: $150,000

Project 1538: Fever of unknown etiology caused by arboviruses in the Black Sea region – clinical specimens will be shipped to the CDC Laboratory for analyses

Duration: 30/09/2017 – 29/09/2020

Funding: $100,360CDC Projects in Georgia1 of 15  

In conclusion, the United States has been consistently developing its laboratory facilities in the Caucasus. Why has the US Government spent billions of dollars on such biolaboratories and projects abroad instead on the health of its own citizens?Scientists with diplomatic immunity1 of 6  

Six diplomatic cars in the car park of the laboratory, all of them with registration plates of the US Embassy.
Six diplomatic cars in the car park of the laboratory, all of them with registration plates of the US Embassy.
Six diplomatic cars in the car park of the laboratory, all of them with registration plates of the US Embassy.
Six diplomatic cars in the car park of the laboratory, all of them with registration plates of the US Embassy.
Six diplomatic cars in the car park of the laboratory, all of them with registration plates of the US Embassy.
Six diplomatic cars in the car park of the laboratory, all of them with registration plates of the US Embassy.

Furthermore, why have US scientists working at the Lugar Center been given diplomatic status and immunity to research deadly pathogens and insects in Georgia? Diplomatic immunity is a principle of international law by which foreign government officials are not subject to the jurisdiction of local courts and other authorities for their activities. Hence, US scientists could even perform illegal experiments in Georgia without being prosecuted as they have diplomatic immunity.

The Internet has generated this and sent it my way, I don’t know who to credit, but it’s a good job, no lies detected as of now.

UPDATE MARCH 10, 2022: Klaus Schwab & Hunter Biden Connected To Ukraine Bio-Labs

I was working on exposing these connections myself, but Infowars moved faster and they did great job. So I can vouch for almost every sentence there based on my own research and I will take it even further. Until then, enjoy their video:

The Gateway Pundit identified through the Wayback Machine that Rosemont Seneca provided capital (invested in) Metabiota as noted on the firm’s website back in 2014.

It is listed as “Our Team’s Investments” on the Rosemont Senaca webpage.

We also located a number of documents from the Wayback Machine (meaning they have been since deleted off the Internet) that show the Department of Defense investing in the creation of Biolabs in Ukraine with the help of firm Black & Veatch.

Here is a sample of one of the documents located.  (We’ve located nearly a dozen of these documents.)

Kiev Ivm Fact Sheet Eng2 by Jim Hoft on Scribd

Metabiota publicized its relationship with Black & Veach in 2018:

Today, Metabiota, the pioneer in epidemic risk modeling, announced it has been awarded a subcontract from Black & Veatch (B&V) to support the U.S. Defense Threat Reduction Agency’s (DTRA) Cooperative Biological Engagement Program (CBEP) in Iraq under the Biological Threat Reduction Integrating Contract (BTRIC). Metabiota has also partnered with B&V on DTRA’s recently awarded Cooperative Threat Reduction Integrating Contract (CTRIC) III with an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract ceiling of $970M.

Metabiota, a pandemic tracking and response firm that has collaborated with Peter Daszak’s EcoHealth Alliance and the Wuhan Institute of Virology, was a primary financial backer of Rosemont Seneca Technology Partners, an investment group led by Hunter Biden.

Rosemont Seneca Technology Partners (RSTP) was a spinoff of Rosemont Capital, a venture capital firm created by Biden and John Kerry’s stepson in 2009. Biden served as a Managing Director. 

Flashback: Hunter Biden’s investment firm led financing for key partners of Wuhan lab

Analysis by WorldTribune Staff, March 1, 2022

<<Hunter Biden’s shady business dealings are becoming harder for the major media to suppress amid revelations coming out of an ongoing grand jury investigation and his business partner’s prison sentence in a scheme to defraud a Native American tribe of some $60 million in bonds.

Which brings us back to a topic many have forgotten if they even knew: The proximity between Hunter Biden and the origins of COVID-19.

Hunter Biden

Independent media outlet The National Pulse reported in June of last year that an investment firm led by Hunter Biden was a key financial collaborator with Peter Daszak’s EcoHealth Alliance and the Wuhan Institute of Virology.

Rosemont Seneca Technology Partners (RSTP), the firm led by Joe Biden’s son, was a lead financial backer of Metabiota, a pandemic tracking and response firm that partnered with EcoHealth Alliance and the Wuhan lab, the report said.

EcoHealth Alliance, headed by Daszak, and financed by several U.S. government agencies, partnered with Dr. Ralph Baric of the University of North Carolina and Dr. Shi Zhengli of the Wuhan Institute of Virology to conduct gain-of-function research on bat-borne coronaviruses in communist China prior to the initial outbreak of Covid.

The National Pulse cited financial reports which show that RSTP led Metabiota’s first round of funding, which amounted to $30 million.

“Former Managing Director and co-founder of RSTP Neil Callahan – a name that appears many times on Hunter Biden’s hard drive – also sits on Metabiota’s Board of Advisors,” the report noted.

In April 2021, Joe Biden’s USAID announced a new initiative spearheaded by EcoHealth Alliance to track emerging infectious diseases with pandemic potential. Also collaborating on the taxpayer-funded venture was Metabiota.

Since 2014, Metabiota has been a partner of EcoHealth Alliance as part of the U.S. Agency for International Development’s (USAID) “PREDICT” project, which seeks to “predict and prevent global emerging disease threats.” As part of this effort, researchers from Metabiota, EcoHealth Alliance, and the Wuhan Institute of Virology collaborated on a study relating to bat infectious diseases in China.

Daszak is also central figure in the potential origins of Covid. His EcoHealth Alliance funneled taxpayer dollars from Anthony Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) to collaborate on bat coronavirus research in Wuhan.

Meanwhile, Hunter Biden’s business partner Devon Archer on Monday was sentenced to one year and one day in federal prison by Manhattan Judge Ronnie Abrams.

“There’s no dispute about the harm caused to real people,” Abrams said, noting that the defrauded tribe, the Oglala Sioux, is one of the poorest in the nation. Archer will also have to pay more than $15 million in forfeiture by himself and more than $43 million in restitution with his co-defendants in the case.

Rosemont Seneca was one of a handful of companies listed in a May 2019 grand jury subpoena that ordered JP Morgan Chase to provide records of transactions between Hunter Biden’s various ventures and the Bank of China for the previous five years.

The subpoena also asked for similar “records, documents and accounts” related to James Biden, Joe Biden’s brother, and Hunter’s former business partners Eric Schwerin and Archer, both founding partners at Rosemont Seneca.

Archer’s attorney, Matthew Schwartz, confirmed that his client had “cooperated completely” with the Department of Justice after the subpoena was leaked online last month by Marco Polo which is preparing a comprehensive report on the Biden family.

“The document offered the first real clues as to the specifics of Delaware U.S. Attorney David Weiss’s probe, which was launched in late 2018 but controversially kept under wraps until weeks after the 2020 Presidential election, supposedly to avoid becoming a campaign issue,” the Daily Mail noted.>>

Update March 30, 2020: Once we pull it out you better pick up on it quickly, I told you we’re in the business of dictating future MSM headlines. But without the sugar glazing. 🙂

Knight Spirit makes a nice summary of the Metabiota – Covid connection:

Metabiota & COVID-19 origin

<<Since 2014, Metabiota has been a partner of EcoHealth Alliance as part of the “PREDICT” initiative of the U.S. Agency for International Development’s (USAID), which aims to “predict and prevent global emerging disease threats.”

As part of this endeavor, researchers from Metabiota, EcoHealth Alliance, and the Wuhan Institute of Virology collaborated on a study into bat infectious diseases in China. According to the research, “sensitive and broadly reactive RT-PCR assays were performed at Wuhan Institute of Virology, Chinese Academy of Sciences.”

Shi Zhengli, the Director of the Center for Emerging Infectious Diseases at the Chinese Communist Party’s Wuhan Lab, is one of the researchers included in the aforementioned 2014 publication. Peter Daszak, who was recently removed from the Lancet COVID-19 panel due to many conflicts of interest as a “longtime collaborator” of the Wuhan Institute of Virology, is named as a contributor.

Daszak is also a key figure in COVID-19’s possible origins. His EcoHealth Alliance used public funds to collaborate on bat coronavirus research in Wuhan with Anthony Fauci’s National Institute of Allergy and Infectious Diseases (NIAID).

EcoHealth Alliance and Metabiota researchers have also worked together on presentations on how to “live safely with bats” and studies tying new infectious disease epidemics to wildlife trade facilities, such as “wet markets.”

“Wildlife trade can facilitate zoonotic disease transmission and represents a threat to human health and economies in Asia, highlighted by the 2003 SARS coronavirus outbreak, where a Chinese wildlife market facilitated pathogen transmission,” the 2016 paper notes.

End slide of presentation. (Screenshot via TheBL)

On a 2014 study on henipavirus spillover, a 2014 study on Ebola monitoring, a 2015 study on herpes, and a 2015 study on viral diversity, Metabiota researchers were named with EcoHealth Alliance staff.

Aside from its ties to EcoHealth Alliance, Metabiota has also been criticized for “bungling” America’s Ebola response.>>

BUT METABIOTA IS INVOLVED IN MANY PLACES AND MANY BITHREATS, SUCH AS:

ABOUT PREDICT

PREDICT is enabling global surveillance for viruses that may spillover from animal hosts to people by building capacities to detect and discover viruses of pandemic potential. The project is part of USAID’s Emerging Pandemic Threats program and is led by the UC Davis One Health Institute. The core partners are USAID, EcoHealth Alliance, Metabiota, Wildlife Conservation Society, and Smithsonian Institution. Scientists work in 30 countries in Africa and Asia testing for five viral families—coronaviruses (e.g. SARS/MERS), filoviruses (e.g. Ebola), paramyxoviruses (e.g. Nipah / Hendra), influenza viruses (e.g. H1N1, H5N1, H7N9) and flaviviruses (e.g. Zika)—in wildlife, livestock, and humans, to understand the risk of spillover. As part of this effort, lab scientists around the world are trained to perform viral testing—a vital skill in case an outbreak should emerge. Field researchers are trained to safely handle and sample animals by capture and release. – SOURCE

Researchers from Metabiota have also been listed alongside EcoHealth Alliance personnel on a 2014 study on henipavirus [aka Nipah – keep this in mind – S.m.] spillover, 2014 study on Ebola monitoring, 2015 study focusing on herpes, and 2015 study on viral diversity.

CBS IS TALKING ABOUT THIS DR. WOLFE
MORE ABOUT TERRAMAR HERE

“An American company that bills itself as a pioneer in tracking emerging epidemics made a series of costly mistakes during the 2014 Ebola outbreak that swept across West Africa — with employees feuding with fellow responders, contributing to misdiagnosed Ebola cases and repeatedly misreading the trajectory of the virus,” an Associated Press (AP) investigation into the company found.

The company reportedly made the “already chaotic situation worse,” prompting World Health Organization officials to criticize the company.

Emails obtained by AP and interviews with aid workers on the ground show that some of the company’s actions made an already chaotic situation worse.

WHO outbreak expert Dr. Eric Bertherat wrote to colleagues in a July 17, 2014, email about misdiagnoses and “total confusion” at the Sierra Leone government lab Metabiota shared with Tulane University in the city of Kenema. He said there was “no tracking of the samples” and “absolutely no control on what is being done.”

“This is a situation that WHO can no longer endorse,” he wrote.

AND THEN, SAME DAY THIS HIT!

<<A separate document detailing Ukraine’s biolab network from the BioWeapons Prevention Project outlines in greater detail the scope of pathogens the facility has conducted research with.

Among the viruses the lab studied were Ebola and “viruses of pathogencity group II by using of virology, molecular, serologica and express methods.”

Additionally, the lab provided “special training for specialists on biosafety and biosecurity issues during handling of dangerous biological pathogenic agents.”>> – National Pulse

BIOLAB’S PATHOGENS.

Look again and tell me if that virus list reminds you of anything. Hint:

URGENT! DEBUNKING THE NEXT ENGINEERED PANDEMIC: HEMORRHAGIC FEVER (NIPAH, MARBURG, EBOLA)

Fmr Assistant Secretary of Defense Andrew Weber, spills more beans about biolabs in a 2017 Ted Talk

MORE FLASHBACK FILES:

INDIA BLACKLISTED US CDC FOR SECRETLY FUNDING BIOWEAPONS RESEARCH IN MANIPAL

India being targeted by the DTRA program too:

This above quotes a National Defense Magazine article, which reveals the Covid narrative was already being set up in 2011, as we’ve shown in other reports too:

<<Teams are learning that local health clinics in South Asia, Africa and Southeast Asia possess deadly pathogens, not as potential weapons, but because they need samples of naturally-occurring diseases on hand to diagnose outbreaks in their human and animal populations. These samples are often kept in public repositories where the microbes could easily be stolen and released.

“We’re looking for partners in new areas around the world who have legitimate need for maintaining samples of these horrible diseases and pathogens,” Myers said, according to National Defense Magazine. “We are looking for ways to partner with them to increase their ability to keep them secure and safe, to be able to account for them so they know exactly how many strains of pathogen X or pathogen Y or pathogen Z they might have.”

The cooperative biological engagement teams are also seeking to assist the partner nations with epidemiological training to ensure scientists are effective and efficient at identifying outbreaks and alerting the proper authorities.

“Many of the countries we’re dealing with now never had any intention of being a threat to the United States,” Myers said, according to National Defense Magazine. “One of their interests in engaging with us is to become real partners with us, and we look forward to developing those relationships.”>> –

Uzbekistan is on their map too

IF YOU THINK THE PENTAGON OR THE CDC ACT BETTER AT HOME…

HUNDREDS DEADLY BIOLABS WITH DISASTREOUS SECURITY RECORDS, RAN BY CDC AND PHARMAFIA IN YOUR BACKYARD

Fort Detrick lab shut down after failed safety inspection; all research halted indefinitely

The Frederick News-Post, Aug 3, 2019

USAMRIID
The U.S. Army Medical Research Institute of Infectious Diseases at Fort Detrick.News-Post file photo

All research at a Fort Detrick laboratory that handles high-level disease-causing material, such as Ebola, is on hold indefinitely after the Centers for Disease Control and Prevention found the organization failed to meet biosafety standards.

No infectious pathogens, or disease-causing material, have been found outside authorized areas at the U.S. Army Medical Research Institute of Infectious Diseases.

The CDC inspected the military research institute in June and inspectors found several areas of concern in standard operating procedures, which are in place to protect workers in biosafety level 3 and 4 laboratories, spokeswoman Caree Vander Linden confirmed in an email Friday.

The CDC sent a cease and desist order in July.

After USAMRIID received the order from the CDC, its registration with the Federal Select Agent Program, which oversees disease-causing material use and possession, was suspended. That suspension effectively halted all biological select agents and toxin research at USAMRIID, Vander Linden said in her email.

The Federal Select Agent Program does not comment on whether a program such as USAMRIID is registered and cannot comment on action taken to enforce regulations, Kathryn Harben, a spokeswoman for the CDC, wrote in an email.

“As situations warrant, [Federal Select Agent Program] will take whatever appropriate action is necessary to resolve any departures from regulatory compliance in order to help ensure the safety and security of work with select agents and toxins,” Harben said in the email.

The suspension was due to multiple causes, including failure to follow local procedures and a lack of periodic recertification training for workers in the biocontainment laboratories, according to Vander Linden. The wastewater decontamination system also failed to meet standards set by the Federal Select Agent Program, Vander Linden said in a follow-up email.

“To maximize the safety of our employees, there are multiple layers of protective equipment and validated processes,” she said.

Vander Linden could not say when the laboratory would be able to continue research.

“USAMRIID will return to fully operational status upon meeting benchmark requirements for biosafety,” she said in an email. “We will resume operations when the Army and the CDC are satisfied that USAMRIID can safely and consistently meet all standards.”

USAMRIID has been working on modified biosafety level 3 procedures and a new decontamination system since flooding in May 2018. This “increased the operational complexity of bio-containment laboratory research activities within the Institute,” she said.

At the time of the cease and desist order, USAMRIID scientists were working with agents known to cause tularemia, also called deer fly or rabbit fever, the plague and Venezuelan equine encephalitis, all of which were worked on in a biosafety level 3 laboratory. Researchers were also working with the Ebola virus in a biosafety level 4 lab, Vander Linden said.

Of the pathogens, Ebola, bacteria Yersinia pestis (plague), and bacterium Francisella tularensis (tularemia) are on the list of the Health and Human Services select agents and toxins. The three are considered Tier 1 agents, which pose a severe public health and safety threat.

Venezuelan equine encephalitis also falls under the Federal Select Agent Program, according to the Code of Federal Regulations.

The military research institute is looking at each of its contracts to see what will be affected by the shutdown. USARMIID work outside the lab is not expected to be affected, including on Ebola, Vander Linden said.

“We are coordinating closely with the CDC to ensure that critical, ongoing studies within bio-containment laboratories are completed under appropriate oversight and that research animals will continue to be cared for in accordance with all regulations,” she said in an email. “Although much of USAMRIID’s research is currently on hold, the Institute will continue its critical clinical diagnostic mission and will still be able to provide medical and subject matter expertise as needed to support the response to an infectious disease threat or other contingency.”

According to the Code of Federal Regulations, which also lists required training, records and biosafety plans, Federal Select Agents Program registration can be suspended to protect public health and safety. It is not clear if this is why the USAMRIID registration was suspended.

The code also gives the Department of Health and Human Services, under which the CDC falls, the right to inspect any site and records, without prior notifications. Vander Linden said in the email that the CDC inspected USAMRIID several times over the past year, both unannounced and on a regularly scheduled basis.

USAMRIID will work to meet requirements set by the Army and the CDC and have its suspension lifted, Vander Linden said.

“While the Institute’s research mission is critical, the safety of the workforce and community is paramount,” she said. “USAMRIID is taking the opportunity to correct deficiencies, build upon strengths, and create a stronger and safer foundation for the future.”

FOLLOW UP STORY:

UKRAINE BIOLABS: OF COURSE FACT CHECKERS LIED ABOUT THIS TOO

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

Remember Silverstein, the dude who cashed some billions insurance for the WTC towers that fell on 9/11?
I’ve often likened that event and the Plandemic and guess what: the Plandemic has its own Silversteins. Possibly same ones at the top of the tops.

About a year ago I wrote a big expose on how the banksters and the mob that gravitate around the World Bank set up the current world order and the Plandemic. I’m afraid you have to start there, no way around it if you want to get the big picture.
Also read: (1ST ANNIVERSARY SPECIAL) SOROS A ROTHSCHILD FRONTMAN, FORGED IMF-CHINA ALLIANCE. WE’RE LIVING THE CONSEQUENCES
I’ve never stopped adding evidence since and it’s overflowing. This new piece deserves its own feature.

THE SHORT COURSE

THE LONG COURSE, BECAUSE EVIL HIDES IN DETAILS

May 2016 – The World Bank announces the creation of the Pandemic Emergency Financing Facility (PEF)

The event took place at the G7 Finance Ministers and Central Governors meeting in Sendai, Japan. The PEF is a scheme to channel funding to countries facing a major disease outbreak with pandemic potential.

2017 – The creation of the Global Preparedness Monitoring Board

The Global Preparedness Monitoring Board (GPMB) is an independent monitoring and accountability body co-convened by the World Bank and World Health Organization, created in response to recommendations by the UN Secretary General’s Global Health Crises Task Force in 2017.

Despite progress made since the West Africa Ebola crisis in 2014/15, GPMB’s 2019 report, A World At Risk noted an increasingly dire risk of widespread epidemics, and found that the world remained unprepared. GPMB warned that epidemic-prone diseases like Ebola, influenza and SARS were increasingly difficult to manage in the face of prolonged conflict, fragile states, and forced migration.

June 2017 – World Bank Launches First-Ever Pandemic Bonds to Support $500 Million Pandemic Emergency Financing Facility

Washington, DC, June 28, 2017 – The World Bank (International Bank for Reconstruction and Development) today launched specialized bonds aimed at providing financial support to the Pandemic Emergency Financing Facility (PEF), a facility created by the World Bank to channel surge funding to developing countries facing the risk of a pandemic.

This marks the first time that World Bank bonds are being used to finance efforts against infectious diseases, and the first time that pandemic risk in low-income countries is being transferred to the financial markets.

The PEF will provide more than $500 million to cover developing countries against the risk of pandemic outbreaks over the next five years, through a combination of bonds and derivatives priced today, a cash window, and future commitments from donor countries for additional coverage.

The transaction, that enables PEF to potentially save millions of lives, was oversubscribed by 200% reflecting an overwhelmingly positive reception from investors and a high level of confidence in the new World Bank sponsored instrument. With such strong demand, the World Bank was able to price the transaction well below the original guidance from the market. The total amount of risk transferred to the market through the bonds and derivatives is $425 million.

“With this new facility, we have taken a momentous step that has the potential to save millions of lives and entire economies from one of the greatest systemic threats we face,” World Bank Group President Jim Yong Kim said. “We are moving away from the cycle of panic and neglect that has characterized so much of our approach to pandemics. We are leveraging our capital market expertise, our deep understanding of the health sector, our experience overcoming development challenges, and our strong relationships with donors and the insurance industry to serve the world’s poorest people. This creates an entirely new market for pandemic risk insurance. Drawing on lessons from the Ebola Outbreak in West Africa, the Facility will help improve health security for everyone. I especially want to thank the World Health Organization and the governments of Japan and Germany for their support in launching this new mechanism.”

Source

The World Bank announced the creation of the PEF in May 2016 at the G7 Finance Ministers and Central Governors meeting in Sendai, Japan. The PEF will quickly channel funding to countries facing a major disease outbreak with pandemic potential. Its unique financing structure combines funding from the bonds issued today with over-the-counter derivatives that transfer pandemic outbreak risk to derivative counterparties. The structure was designed to attract a wider, more diverse set of investors.

The PEF has two windows. The first is an ‘insurance’ window with premiums funded by Japan and Germany, consisting of bonds and swaps including those executed today. The second is a ‘cash’ window, for which Germany provided initial funding of Euro 50 million. The cash window will be available from 2018 for the containment of diseases that may not be eligible for funding under the insurance window.

The bonds and derivatives for the PEF’s ‘insurance’ window were developed by the World Bank Treasury in cooperation with leading reinsurance companies Swiss Re and Munich Re. AIR Worldwide was the sole modeler, using the AIR Pandemic Model to provide expert risk analysis. Swiss Re Capital Markets is the sole book runner for the transaction. Swiss Re Capital Markets and Munich Re are the joint structuring agents. Munich Re and GC Securities, a division of MMC Securities LLC are co-managers.

Swiss Re Capital Markets Limited, Munich Re and GC Securities were also joint arrangers on the derivatives transactions.

The bonds will be issued under IBRD’s “capital at risk” program because investors bear the risk of losing part or all of their investment in the bond if an epidemic event triggers pay-outs to eligible countries covered under the PEF.

The PEF covers six viruses that are most likely to cause a pandemic. These include new Orthomyxoviruses (new influenza pandemic virus A), Coronaviridae (SARS, MERS), Filoviridae (Ebola, Marburg) and other zoonotic diseases (Crimean Congo, Rift Valley, Lassa fever).

PEF financing to eligible countries will be triggered when an outbreak reaches predetermined levels of contagion, including number of deaths; the speed of the spread of the disease; and whether the disease crosses international borders.

The determinations for the trigger are made based on publicly available data as reported by the World Health Organization (WHO).

Countries eligible for financing under the PEF’s insurance window are members of the International Development Association (IDA), the institution of the World Bank Group that provides concessional finance for the world’s poorest countries. The PEF will be governed by a Steering Body, whose voting members include Japan and Germany. WHO and the World Bank serve as non-voting members.

The World Bank has developed some of the most innovative catastrophe risk insurance instruments in the market to help developing countries manage risk. In the past ten years the institution has executed approximately $1.6 billion in catastrophe risk transactions.

IBRD Pandemic Bonds Distribution by Investor Type and Location
Distribution by Investor TypeClass AClass B
Dedicated Catastrophe Bond Investor61.7%35.3%
Endowment3.3%6.3%
Asset Manager20.6%16.3%
Pension Fund14.4%42.1%
Distribution by Investor LocationClass AClass B
US27.9%15.0%
Europe71.8%82.9%
Bermuda0.1%2.1%
Japan0.2%0.0%
IBRD Pandemic Bonds Summary Terms and Conditions*
Type of NoteClass AClass B
Issuer:International Bank for Reconstruction and DevelopmentInternational Bank for Reconstruction and Development
Trade Date:June 28, 2017June 28, 2017
Final Size (Bond only)**USD 225 millionUSD 95 million
Settlement Date:July 7, 2017 July 7, 2017
Scheduled Maturity Date:July 15, 2020 extendable monthly in whole or in part, up to a maximum of 12 months following the Scheduled Maturity DateJuly 15, 2020 extendable monthly in whole or in part, up to a maximum of 12 months following the Scheduled Maturity Date
Issue Price:100%100%
Bond Coupon:6m USD LIBOR +6.50%6m USD LIBOR +11.10%
Covered Perils:Flu, CoronavirusFilovirus, Coronavirus, Lassa Fever, Rift Valley Fever and Crimean Congo Hemorrhagic Fever
Redemption Amount:The Notes will not be fully repaid if an event occursThe Notes will not be fully repaid if an event occurs

 (*) Please see the Supplemental Prospectus for a detailed description of the Terms and Conditions of the bonds, the related risks with regard to an investment in the bonds and the relevant offering restrictions. Any offer of the bonds will solely take place on the basis of the Supplemental Prospectus prepared by the World Bank or on behalf of the World Bank. 
(**) There was an additional $105 million size done in the derivatives market.

Our take out from this?
Remember the strange numbers reported during the first “casedemic of 2020”? They determined how much money WB pays and to whom.
But WB and the funky bunch are also behind WHO, so it’s safe to say controlled the situation at all times and could arbitrarily decide whatever.

WORLD BANK SAYS COVID-19 TEST KITS ARE BEING SOLD SINCE 2017

2018 – World Bank Group’s Pandemic Emergency Financing Facility (PEF) Welcomes Australia as New Donor

WASHINGTON, JUNE 21, 2018 — The World Bank Group’s Pandemic Emergency Financing Facility (PEF)  welcomes Australia as a donor to the PEF, joining Japan and Germany. Australia is contributing US$7.2 million to the PEF’s Cash Window, which was set up through an initial contribution from Germany. Australia will also now be a voting member of the PEF Steering Body.

“With this contribution to the PEF, Australia is supporting the scaling up of national and international responses to infectious disease outbreaks,” said the Hon Julie Bishop MP, Minister for Foreign Affairs, Australia“We are committed to working with international partners to reduce the risk of global pandemics and improve health security for all.”

“The PEF ensures that we break the cycle of panic and neglect which has so far characterized the global approach to pandemics,” said Annette Dixon, Vice President, Human Development at the World Bank Group. “It is a key example of the World Bank Group’s commitment to creating innovative financing mechanisms to tackle complex global challenges, working with country governments, donors, international partners and the private sector.”

“The robust and swift contribution of the PEF just in the past week has underlined its role as a new model for financing pandemic response with speed and flexibility,” said Mukesh Chawla, Coordinator of the PEF and Advisor, World Bank Group. “It ensures that money is never the reason holding back effective response.”

The PEF, set up by the World Bank Group in partnership with Japan, Germany, the World Health Organization (WHO), and private sector partners, has been operational since July 2017 and consists of both a cash and an insurance component.  The PEF’s $425 million Insurance Window with premiums funded by Japan and Germany, consists of bonds placed on the capital markets. This would be triggered if a much larger, multi-country response is needed. All activation criteria are based upon publicly available data provided by the WHO. The PEF covers 78 of the world’s poorest countries against pandemic threats and is the first mechanism to be expressly designed for this purpose.


Source

May 2019 – updates on Pandemic Emergency Financing Facility


Image

Click here to zoom in.


The Pandemic Emergency Financing Facility (PEF) – a financing mechanism housed at the World Bank  –  is designed to provide an additional source of financing to help the world’s poorest countries respond to cross-border, large-scale outbreaks.  The PEF complements the much larger role that IDA, the World Bank’s fund for the poorest countries, and other international organizations and donors play in financing outbreak response. The PEF’s design is unique in that payments can go directly to governments and pre-approved frontline responder organizations (such as WHO & UNICEF) and it can do so through either its cash window — or once triggered through its insurance window.

Pandemic Emergency Financing Facility (PEF) Framework

PEF Operational Brief

PEF Operations Manual

PEF Accreditation Guidelines

PEF Prospectus (Term Sheet)

PEF Brochure | Spanish | French | Russian

February 2020 – Is the whole thing is designed to fail?

The Street does a really good job at explaining the scheme:
“In June 2017, the World Bank — the international financial institution that provides loans to poorer countries — sold around $425 million (€391 million) worth of bonds and derivatives aimed at providing financial support to developing countries facing the risk of a pandemic.

The less risky tranche of the bonds will not be paid back to investors if there are more than 2,500 deaths in developing countries as a result of a pandemic. Although China has recorded more than this number of deaths, the World Bank does not designate it a developing country.

By far the riskier of the two bonds is “Class B,” which sold $95 million in bonds (compared to $225 million for the less risky “Class A,” explained above). For Class B, if the disease crosses an international border and if there are at least 20 deaths in that second country, the investors’ money will be paid to developing countries dealing with the outbreak.

I do not come up with $425 million total. $225 million plus $95 million does not total $425 million.

Only those class B bonds are going to trigger.

An international crisis is brewing. There are 19 deaths in Iran, 12 in Italy, and 12 in South Korea.

One more death in Iran is all it takes unless there are other restrictions.

Designed to Fail

Bodo Ellmers, the director of the Global Policy Forum’s sustainable development finance program told the Financial Times the instrument was “useless.”

You obviously want to prevent a pandemic but it only pays out when it becomes a pandemic,” he said.

Olga Jones, who worked as an economist at the World Bank for three decades, said it was absurd that discussions for a second round of bonds for what is known officially as the Pandemic Emergency Financing Facility (PEF) had begun, as they were effectively “designed to fail.”

Many critics have also pointed to the fact that the severe attack of Ebola that hit the Democratic Republic of Congo in 2018 did not meet the conditions to trigger payment of the pandemic bonds despite the fact that almost 500 people died and that it was one of the largest outbreaks ever recorded.

Payout and Maturity

The Class A bonds feature an interest rate of 7% while the Class B bonds’ rate is 11%.

According to the PEF, around $75.5 million had been paid to bondholders in the form of premiums as of August 2019. The full amount paid in interest and coupons has not been disclosed. The bonds are set to mature in July 2020.

Painful Problem

The Wall Street Journal discusses the Painful Problem With Pandemic Bonds

“The idea behind pandemic bonds, issued by the World Bank in 2017, is simple: They pay investors a solid return, but if a pandemic breaks out, the principal is redirected to help low-income countries pay for their emergency response.

An investor who doesn’t do the legwork is liable to get burned when the bonds don’t behave as expected. At 386 pages, the prospectus for the World Bank’s class-B securities isn’t a light read.

The second and larger problem with pandemic bonds is one they don’t share with other catastrophe-related securities. During extreme events, they don’t offer a source of returns uncorrelated with major capital markets—one of the things buyers like most about the asset class.

Pandemic bonds are most likely to be triggered just as equities tumble and concerns about companies’ ability to finance themselves come to the fore, as now. In short, the asset class is uncorrelated with wider markets—except at the exact moment when that matters most. Then it is suddenly very correlated.”

Questions Abound

These bonds pay interest. How does the Wold Bank pay that interest?

Generally, companies issue bonds for expansion and expect to pay the debt back from future profits or current income.

What is the World Bank invested in or doing with the money to pay way above market rates?

Only the $95 million in class B bonds will trigger. But at 11% interest with a maturity date coming up, most of that money has been paid out.

Even if some developing nations do end up receiving pandemic bond money, it will be a trivial sum when compared with the economic damage from a sustained coronavirus pandemic.

Meanwhile the class A bond buyers have been collecting 7% with virtually no chance of losing their money by July of 2020 because China is not a developing nation.

The whole setup makes no sense unless failure was the intent all along.” – The Street

Or, unless it’s designed to not trigger more than conveniently, like electronic poker. – Silview

Intent is the hardest thing to demonstrate in the justice system. Except in this case. WB put years of effort in elaborating a “maze of confusion” when it comes to the bonds’ triggers, to avoid payment, as a former WB expert testifies in the Bloomberg video below. All that effort weighs now as evidence of premeditation. There’s literally a few kilos of evidence available, if printed.

The Guardian got it, but can’t fully say it

World Bank’s $500m pandemic scheme accused of ‘waiting for people to die’

Bonds designed to provide fast funding for poor countries branded ‘obscene’ because of complex payout criteria

A flagship $500m World Bank scheme to help the poorest countries deal with a health emergency is “too little too late” for the coronavirus outbreak, say health experts.

The first pandemic emergency financing (PEF) bonds were launched in 2017 by Jim Yong Kim, the bank’s president at the time, after the Ebola outbreak in west Africa. Designed to potentially “save millions of lives and entire economies” by speedily funnelling money to nations facing pandemics.

But critics say the “insanely complicated” terms of the high-interest bonds are heavily skewed towards investors, while for the victims any payouts may come too late, if at all.

One economist described the bonds, payouts from which depend on how deadly the outbreak is, as “obscene”.

Olga Jonas, a senior fellow at Harvard Global Health Institute who was an economist at the World Bank for three decades, said: “The whole mechanism is highly unfortunate. The objectives were to help the poorest countries respond quickly to outbreaks. Infectious disease spreads exponentially and the coronavirus has a very rapid growth rate. But the bonds only get triggered when the disease has spread for a long time.”

Jonas, who has analysed the bonds’ terms, said they were “so convoluted, it is not at all clear whether they will pay out at all. It is too little, too late – and in this case, maybe never.

“What’s obscene is that the World Bank set it up this way. It waits for people to die.”

Funds can only be released after a certain amount of time and in accordance with complex criteria including outbreak size, growth rate, deadlines and death tolls. In the case of coronavirus, the bonds would not pay out until 12 weeks after the World Health Organization (WHO) publishes its first “situation report”, which would not be until 23 March. Another criterion is that the outbreak is still growing.

The bonds, funded by donor nations Japan and Germany, deliver interest payments to investors until the conditions for an infectious disease outbreak are triggered.

The value of the bonds has halved as the coronavirus outbreak has spread, raising fears investors could face losses.

Meanwhile, the WHO has appealed for £520m for “frontline efforts” to contain coronavirus. The disease has infected more than 82,000 people and killed over 2,800 people in 51 countries to date, but has not yet been declared a pandemic by the WHO.

Clare Wenham, assistant professor in global health policy at the London School of Economics, said: “If you really wanted to ensure global health security you would link the payout of the bonds to a decision around declaring a public health emergency of international concern or a national emergency.”

Wenham co-authored a paper criticising pandemic bonds in which it was found that more money was paid out to investors than to countries facing disease outbreaks. Payments would have only been triggered in two out of more than 60 disease outbreaks analysed – Ebola in west Africa and rift valley fever in 2006, the paper found.

Wenham said: “If the aim of it is to prevent pandemics, why would you wait for arbitrary numbers? Global health security is predicated on prevention rather than response, so waiting for it to get to a certain number of deaths in a certain number of countries before they pay out, is counterintuitive. It is not fit for purpose.

“No one has thought about it holistically. If public health officials have made a declaration of a global health emergency of international concern, there should be some mechanism for financing so that the WHO doesn’t have to go around the houses asking for money.”

Bodo Ellmers, director of Global Policy Forum’s sustainable development finance programme, said: “The idea was that it would be a quick instrument, but it was set up with such stringent criteria that the risk for investors is very low. The design, taking the number of dead people as a criteria, is very cynical.”

The scheme’s “fundamental flaw” is that it was aimed at preventing a pandemic but would only pay out when a pandemic was already underway, said Ellmers.

The World Bank said a PEF payout had been triggered after the Ebola outbreak of 2018 and 2019 in the Democratic Republic of the Congo, providing a total of $61.4m to fight the disease.

The bank added that it has rolled out a series of tools to better assist countries during critical outbreaks, epidemics and pandemic threats.

It is capable of fast-tracking funds via existing projects and could fund emergency operations within three months – although in past cases, such as Ebola, it had provided support within two weeks.

Around the same time, February 2020, Washington Examiner doesn’t have the guts to put out such conclusion, but confirms pretty much everything else:

“Investors betting big against catastrophic diseases are watching the World Health Organization closely as insurance bonds tied to whether the organization labels COVID-19 a pandemic are set to mature in June.

In 2017, the World Bank designed a new way to raise money: Pandemic Emergency Financing bonds. Over $425 million worth of such bonds, which bet against a global outbreak of infectious diseases and will default if WHO declares the coronavirus a pandemic, were sold by the World Bank in its first-ever issuance of catastrophe bonds. In the event of no pandemic, investors would be paid a healthy annualized return. Meanwhile, the World Bank could use the bonds to insure itself against the risk of a global outbreak.

“As an investor, we do not want to lose money,” said Chin Liu, a portfolio manager at Amundi Pioneer, a Boston-based firm that purchased the bonds as a way to diversify the company’s $1 billion catastrophe fund. “But then, we also understand if it’s unfortunately triggered, it benefits every single person, including ourselves, to keep the virus controlled.”

For large-scale investors looking for above-average returns in a bloated market, the bonds were the next logical place to hedge against disaster. At the time of issuance, then-World Bank President Jim Yong-Kim heralded the bonds as an opportunity to leverage “capital market expertise to serve the world’s poorest people.”

The bonds were administered in two tranches, with Class A bond investors receiving a return of 6.9% annually. Class B bond investors received 11.5% annually. The World Bank raised $225 million in Class A bonds and $95 million in Class B bonds.

The investors, mainly endowments and pension funds, have long bet against natural disasters such as hurricanes, but the 2017 issuance of the bonds marked a shift in the market. Before, investors were betting on the wind speed of hurricanes, but now, they were betting on the likelihood of an infectious disease that could tear through nations across the globe.

“This marks the first time that World Bank bonds are being used to finance efforts against infectious diseases, and the first time that pandemic risk in low-income countries is being transferred to the financial markets,” read a statement from the World Bank at the time of issuance.

The conditions under which the payout on bonds will default are staggered based on how rapidly the disease spreads, the number of deaths associated with the illness, and whether the virus crosses international borders.

March 2020 -more people start to wake up to the scam.

Jacobin Mag: “Twelve weeks passed on March 23, and death is raining down on countries rich and poor. More than 770,000 cases of coronavirus have been reported worldwide, and in some places, infections and deaths are doubling every few days. Yet the World Bank says that eligible countries — so far Afghanistan, Pakistan, Nigeria, Cambodia, Senegal, and Nepal — won’t know if they will get any money until April 9 at the earliest.

This is despicable. Even wealthy countries are failing to contain the deadly virus. Poor countries that, for centuries, have seen their wealth and resources pilfered and plundered by rich nations, are facing down a tidal wave of infection and death without adequate medical supplies and facilities. Millions of people in these countries have compromised immune systems due to malnutrition, live in housing and communities that make social distancing impossible, and lack even the most basic necessities of disease prevention, such as access to water and soap for handwashing.

However, in this moment of crisis, when every second counts, global capital is sitting on its hands, holding desperately needed funds hostage as investors decide whether they are required to honor their end of the deal.

The pandemic bonds were advertised by the World Bank as a great way to “tackle social ills through private investment.” Instead, the bonds are yet another example of how hollow most so-called ESG investment is. They demonstrate how private investors have an uncanny ability to profit from social ills — and how, even in times when global solidarity is desperately needed, global capital can’t seem to look past the bottom line.”

APRIL 2020 – THE WORLD IS SCANDALIZED, THE WORLD BANK ACCEPTS TO PAY A LITTLE OVER HALF THE MONEY

The beginning of the month sees surprising attacks on WB, even from usual allies, who probably have to think of their media reputation before WB’s

So, finally, on April 20, 2020, WB makes the big announcement:

“All activation criteria including outbreak size, spread and growth have been met,” the World Bank said in an update on its website, referring to the coronavirus outbreak, adding PEF bonds and swaps were expected to pay out $195.84 million. (Out of 322 milion – S.m)

A steering body will now meet to determine how to allocate the funds to so-called IDA countries – a group of 76 of the world’s poorest nations, the World Bank said. The committee is made up of Australia, Germany, Japan, the World Health Organization, UNICEF, the World Bank, and two IDA countries – currently Haiti and Liberia…

Campaigners have also been critical of the complex structure of the instrument, which requires five variables on the number of deaths, the velocity of its spread and its geographical spread to be reached before paying out.

This had been an obstacle to quick deployment, said Bodo Ellmers, director of sustainable development finance at Global Policy Forum, an independent policy watchdog.

“If those funds had been paid out earlier they could have been used to prevent the spread in some of those poor countries – the later you intervene the costlier it gets, in terms both of lives and money needed to remedy the situation,” he said.

Deutsche Welle reports: “The World Bank’s bond sale was 200% oversubscribed, meaning investors saw moneymaking opportunities with the high-yield returns on offer. Most buyers came from Europe, and included specialized catastrophe bond investors as well as asset managers and pension funds.

According to Bloomberg, asset managers including Bailie Gifford, Amundi and Stone Ridge Asset Management are among those who hold the riskier Class B bonds.

The interest and coupon payments made to investors have been funded largely by the donor nations Japan and Germany.  The Class A bonds feature an interest rate of 7% while the Class B bonds’ rate is 11%.

According to the PEF, around $75.5 million had been paid to bondholders in the form of premiums as of August 2019. The full amount paid in interest and coupons has not been disclosed. The bonds are set to mature in July 2020.”

We later found out that investors made about 96 million in 2020.
The governments who donated for this have no money of their own, they spend your money.

December – 2020 WB still pounded by media and investors for PEF’s failure:

India Times delivered the best indictment in mainstream media, from what I’ve seen so far:

How pandemic bonds became the world’s most controversial investment

In late January 2015, just after the deadliest outbreak of Ebola in history, then-World Bank President Jim Yong Kim stood in front of a group of Georgetown University students and professors to introduce a new approach to fighting pandemics.

Fresh from the annual gathering of power brokers and policy makers in Davos, Kim described a new type of financial product – “pandemic bonds” – that he hoped would persuade private investors to swell the World Bank’s coffers. …

Five years later, Summers had some different words for Kim, though you probably won’t hear the former World Bank president repeat them in public. The approach was “a dumb idea,” Summers said in a February 2020 email to a Harvard colleague seen by Bloomberg News. Modeled on catastrophe debt that pays insurance claims on natural disasters, the program was too complicated and ultimately unnecessary, he suggested, “like me insuring my toaster.”

Trumpeted by the World Bank at their launch as an innovative example of a public-private partnership, pandemic bonds have since become the subject of intense criticism for failing to divert money fast enough to battle deadly waves of Ebola and Covid-19. Academics from Harvard to the London School of Economics have lambasted the program for being ineffective and expensive, and the World Bank has confirmed it won’t issue a second round of the debt.

But the pandemic bonds weren’t designed to default at the earliest sign of a pandemic. The 386-page prospectus for the debt covered a range of outbreaks including Ebola, influenza and coronaviruses and spelled out very specific conditions for writedown – an effort to automate the typically political process of distributing funds. The list of triggers was long and complex, balancing investors’ desires for a long payout stream with the World Bank’s need to disburse the money to countries that need it. “We had to think through how this instrument should actually function, what kind of diseases should be addressed,” said Ivo Menzinger, who leads the group responsible for public sector solutions at Swiss Re. “During that process it got considerably broader.”…

when Ebola returned in 2018 to ravage West Africa again, the bonds failed to trigger. The virus killed almost 2,300 in the Democratic Republic of Congo, but per the criteria in the prospectus, it didn’t spread far enough, fast enough to qualify as a pandemic. In an effort to avoid political grappling over donor funds, the pandemic bonds relied on mechanical triggers that failed to fire. So investors kept getting paid interest and retained their principal. Meanwhile, the World Bank allocated $61 million from the PEF’s “cash window” – the discretionary portion of money funded by donor contributions – to help fight the outbreaks.

Even when Covid-19 began to sweep the globe earlier this year, it was unclear whether the bonds would get written down. The coronavirus had killed almost 150,000 people in dozens of countries before the casualty rates aligned with the “exponential growth” requirement set out in the bond prospectus. On April 16, more than five weeks after the WHO had declared a global pandemic, AIR Worldwide issued a report confirming that the conditions for a writedown had been met, diverting $132.5 million to the World Bank for disbursement. A further $63.3 million came from the swaps struck with Munich Re and Swiss Re.

“The triggers had to be late and they had to be convoluted and complex to reduce the probability that the financing would be triggered,” says Olga Jonas, a critic of the bonds who worked for more than three decades at the World Bank …

Meanwhile, the World Bank quietly announced it would not be issuing a second round of the debt. Unlike the launch of the pandemic bonds, the news came with little fanfare; it was just one line added to their website.

“The issues raised by COVID-19 are profound and require a deep rethinking of our pandemic response infrastructure,” Kim said. “If we can say that the PEF got it wrong, it wouldn’t be the only institution or instrument that got it wrong.”

Read more at:
https://economictimes.indiatimes.com/markets/bonds/how-pandemic-bonds-became-the-worlds-most-controversial-investment/articleshow/79655582.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

What silview.media makes of all these facts

Learning what we have learned about the World Bank worrying about an impending economic collapse and, in parallel, setting up this pandemic, one may be confused how all this falls together in the grand scheme. Failing to see it is due to overcomplication, I suspect. Brush off the meaningless details and go for the essential questions:

How did this work, most basically?
Fabricated disease fearmongering and unrealistic promises persuaded some fools to transfer money to some con artists, under various pretenses.
WHO benefitted?
The con artists and the Great Reset budgets.
Who lost?
The total morons who haven’t yet learned why it’s not good to swim with sharks, no matter how you see yourself. And if it’s not good to swim with them, giving them money sounds even dumber.
Where have we seen this “business model” before?
Vaccines / WHO / GAVI…

EPILOGUE

APRIL 2021: WHO BOSS MENTIONS THE BONDS ON THE LIST OF THEIR PAST SUCCESSES

Around min. 13 in the video below.

MARCH 2021: WB RELAUNCHES CATASTROPHE BONDS

POP QUIZ: IF YOU PAID ATTENTION, BESIDES CORONAVIRUSES, WHAT OTHER VIRUSES ARE COVERED BY THESE BONDS?

Hint:

URGENT! DEBUNKING THE NEXT ENGINEERED PANDEMIC: HEMORRHAGIC FEVER (NIPAH, MARBURG, EBOLA)

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

This has been revealed to me while investigating Trump’s new “Vaccine Czar” Moncef Slaoui, in his home-town Agadir, Morocco, under a coronavirus lockdown and a hunger-strike. Energy and time are scarce, I’ll be making a brief sum-up here, and for more details please read my other investigations on this site.

The scheme is simple and efficient:

Bill Gates: Money, influence and organizing

Tony Fauci (NIAID): Influence, research and power

through US Government and media with all their capabilities

Moncef Slaoui (GSK, Moderna), US’ new “Vaccine Czar”: concocts the vaccines, connects the industry

Together they control WHO and GAVI, which serve as common platforms and global marketers

The following vaccines have been elaborated and marketed by this group, mostly with disastrous effects:

(Each link shows how each partener contributed)

H1N1 – Pandermix

GATES: https://www.gatesfoundation.org/Media-Center/Press-Releases/2009/09/Statement-on-Global-Agreement-to-Supply-H1N1-Vaccine-to-Developing-Countries

FAUCI: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791488/

There were no serious adverse events that could be attributable to the vaccine.  We’re seeing pain, redness and perhaps some swelling that we see very frequently with injectable vaccines. 

Anthony Fauci

SLAOUI: created Pandemrix

WHO: https://www.who.int/csr/disease/swineflu/en/

Source: Science Mag

Malaria – Mosquirix

SLAOUI: https://www.gsk.com/en-gb/media/press-releases/gsk-s-malaria-candidate-vaccine-mosquirix-rts-s-receives-positive-opinion-from-european-regulators-for-the-prevention-of-malaria-in-young-children-in-sub-saharan-africa/

GATES: https://www.gatesfoundation.org/Media-Center/Press-Releases/2008/09/Bill-Gates-Announces-168-Million-to-Develop-NextGeneration-Malaria-Vaccine

FAUCI eventually recognised the weak efficacy of this vaccine is a scandal and touted a competitor after a while: https://www.nbcnews.com/health/health-news/malaria-vaccine-protects-half-who-try-it-n570656

“This is not the big game changer that we were hoping for,” said Dr. Martin De Smet, a malaria expert at Doctors Without Borders. “The vaccine itself remains disappointing but this is an important step forward,” he said. Still, De Smet said the vaccine could help reduce the huge burden of malaria: there are about 200 million cases and more than 500,000 deaths every year, mostly in African children.

HIV

GATES+FAUCI+SLAOUI: https://www.niaid.nih.gov/news-events/large-scale-hiv-vaccine-trial-launch-south-africa

Source: NIAID
Source

Ebola

GATES: https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2014/10/OPP1120885

FAUCI: https://www.niaid.nih.gov/research/technology-development-success-stories

https://www.niaid.nih.gov/news-events/experimental-ebola-vaccines-elicit-year-long-immune-response

SLAOUI: https://www.gsk.com/en-gb/media/press-releases/ebola-vaccine-trials-fast-tracked-by-international-consortium/

https://news.yahoo.com/gsk-hands-potential-ebola-vaccines-110546227.html

Rotarix

https://www.path.org/media-center/fda-advisory-committee-recommends-us-approval-of-rotavirus-vaccine/

GATES: https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2017/01/OPP1162918

FAUCI: https://www.pbs.org/wgbh/frontline/article/anthony-fauci-risks-from-vaccines-are-almost-nonmeasurable/

SLAOUI: https://www.gsk.com/en-gb/media/press-releases/millions-of-children-in-the-world-s-poorest-countries-could-receive-vaccination-against-rotavirus-diarrhoeal-disease-under-new-offer-made-by-gsk-to-the-gavi-alliance/

WHO: https://www.gsk.com/en-gb/media/press-releases/world-health-organization-grants-global-prequalification-to-gsk-s-rotarix-vaccine/

Source

Fauci doing damage control for the clan:

… and, of course, Moderna’s coronavirus vaccine


GAVI IS THEIR MONEY FIDGET SPINNER TOO

If you haven’t heard yet of Pharmafia’s Country Club aka the GAVI Alliance, you should. I’ll help with the introduction:

“The summit aims to raise at least $7.4 billion (approx. £6 billion) for Gavi to immunise a further 300 million children in the world’s poorest countries by 2025.” – https://www.gov.uk/

Source: GAVI
Surce: GAVI
Source: GAVI

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE